CA2130108C - Heat-releasable reagents for in vitro chemical reactions - Google Patents

Heat-releasable reagents for in vitro chemical reactions

Info

Publication number
CA2130108C
CA2130108C CA002130108A CA2130108A CA2130108C CA 2130108 C CA2130108 C CA 2130108C CA 002130108 A CA002130108 A CA 002130108A CA 2130108 A CA2130108 A CA 2130108A CA 2130108 C CA2130108 C CA 2130108C
Authority
CA
Canada
Prior art keywords
reagent
heat
releasable
entrapped
dispensable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002130108A
Other languages
French (fr)
Other versions
CA2130108A1 (en
Inventor
Kenneth M. Kosak
Matthew K. Kosak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2130108A1 publication Critical patent/CA2130108A1/en
Application granted granted Critical
Publication of CA2130108C publication Critical patent/CA2130108C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6848Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815Carrier is a synthetic polymer
    • Y10S530/817Entrapped within the carrier, e.g. gel, hollow fibre

Abstract

Heat-releasable reagent compositions are disclosed comprising a dispensable body formed from a coating material (D) which entraps a reagent material (B). The entrapped reagent material does not react until the dispensable body is heated to a min-imal temperature. When heated to the predetermined temperature, the reagent is released into the surrounding medium and be-comes available for reaction with other substances in the medium. The heat-releasable reagent compositions are particularly use-ful in various types of nucleic acid hybridizations, polymerase chain reactions (PCR), reverse transcriptase reactions (RTR), nucleic acid sequencing and product generating reactions such as colorimetric, fluorometric and chemiluminescent enzyme lab-eled immunoassays.

Description

W093/16200 213 01 0 ~ PCT/US93/01313 HEAT-P~T~RT~ P~NTS FOR IN VITRo CHEMICAL REACTIONS

FIELD OF THE INVENTION
This invention relates to the preparation and use of reagents that are entrapped in various particulate composi-tions, especially wax beads, and subsequently released by heating for use in various in vitro chemical, biochemical and immunological reactions.

DESCRIPTION OF THE PRIOR ART
A variety of chemical reactions are improved through the addition of heat. Increased temperature is of particular importance in certain biochemical reactions such as nucleic acid hybridizations where heat is frequently used to increase the specificity of the binding reaction. Elevated temperatures (i.e., 70C), are also useful in overcoming problems of secondary RNA structures in the reverse transcriptase reaction (RTR), used to produce complementary DNA (cDNA) from RNA
(BiochemistrY 30, 7661-7666, 1991). Elevated temperatures are also useful in DNA sequencing procedures.
Heat is important in nucleic acid amplification such as the polymerase chain reaction (PCR). The PCR (U.S. Pat. Nos.
4,683,202 and 4,683,195) employs a heating and cooling cycle to drive the reaction. First, the reaction mixture is heated to, or above, the nucleic acid melting temperature (denaturization), then cooled to allow specific oligonucleotide primers to bind to the sample (annealing), and then heated to optimize the addition of complementary bases to the amplified nucleic acid (extension). Using heat stable, Taq DNA polymer-ase (U.S. Pat. No. 4,889,818), this cycle of denaturing, annealing and extension is repeated as many times as needed to generate the desired product.
- The PCR is quic~ly becoming a major tool in molecular biology, and the need for high specificity during amplification is an increasing problem.
One method suggested for increasing the PCR specificity is called "booster" PCR (see application section below), where ~L

initial amplification is done with diluted amounts of primer, that are subsequently increased or "boosted" for later cycles.
Another method for increasing specificity is pre-amplifi-cation heating. This method has been described by H.A. Erlich, et al., Science 252, 1643-1651 (1991), and R.T. D'Aquila, et al., Nucleic Acids Res. 19, 3749 (1991). It requires exclusion of at least one essential reagent (dNTP's, Mg2+, DNA polymerase or primers), from the reaction until it has been heated to the desired annealing temperature. However, the procedure requires the sample tubes to be closed while heating, and reopened for addition of the missing reagent.
The procedure, also called Hot-Start~ PCR by Perkin Elmer Cetus, CT, has been improved by the use of a wax barrier formed in the reaction tube that separates some of the reagents until the tube is heated to melt the barrier, as described in WO
gl/12342. Per~in Elmer Cetus now sells a wax pellet (Ampliwax~) for this purpose. Their published procedure includes: ~1) to a sample tube containing primers, Mg2+, dNTP's in buffer, add one pellet of Ampliwax~; (2) heat the tube to 80C to melt the wax; (3) cool to room temperature to form a wax barrier on top of the solution; (4) over the wax barrier, add the sample with DNA polymerase in buffer; and (5) start normal PCR cycling.
The problems with this method are: (1) it is limited to open tubes and is not readily used in other containers such as sealed capillaries or tubular containers; (2) there is poten-tial for error in forming each wax barrier in each tube; and (3) the melting and cooling of wax adds additional steps to the PCR method.
FR 2627404 discloses a method for encapsulating particles by a layer of material by dropping the particles into a solution of melted covering material.
The methods and reagents disclosed in the references herein are hereby incorporated into this patent application by reference. As will become apparent with the disclosures to follow, the instant invention solves these problems in the PCR
as well as in other high temperature methods such as reverse transcriptase, and nucleic acid hybridizations.

W O 93/16200 2 1 3 ~ 1 ~ 8 PC~r/US93/01313 SU~DMARY OF THE INVENTION
This invention is directed toward the preparation of waxy polymer beads or particles that contain a heat-releasable reagent. The reagent solves the problems of adding stepwise, - 5 one or more essential reagents into a reaction medium when needed, without reopening containers or interrupting the procedure. This invention comprises compositions and methods for preparation and in vitro use of mobile or particulate, entrapped reagents that do not react until heated to a minimal temperature. When heated to the predetermined temperature, the reagents are released into the surrounding medium, such as a solution, and become available for reaction with other sub-stances in the medium. The most preferred applications for this invention are in various types of nucleic acid hybridiza-tions, PCR's, RTR's, nucleic acid sequencing and product generating reactions such as colorimetric, fluorometric and chemiluminescent enzyme labeled immunoassays.
The synthesis method has the following advantages:
1. The reagent to be entrapped is in liquid form inside each bead.
2. Precise and consistent amounts of reagent are entrapped in each bead.
3. The method is readily automated.
4. The method can also incorporate a packaging method.
The resulting composition has the following advantages:
1. A reaction mixture in a solution or some other medium can be prepared that is complete with all of the necessary reagents in place and one or more of the key reagents or substances is suitably entrapped in a heat-releasable, mobile composition. Then, the reaction mixture may be held indefi-nitely and no reaction will occur until the medium is heated to a predetermined temperature.
2. Several identical or different complete reaction mixtures can be prepared and stored as needed, and eventually all reactions can be initiated simultaneously. This avoids the problem of adjusting for product differences in time-sensitive and/or kinetic reactions such as enzymatic production of WO93/16200 PCT/US93/Ot313 213010~
colored, fluorescent or chemiluminescent products used in immunoassays and molecular biology. Also, by using appropriate inhibitors and/or blocking agents as entrapped reagents, all reactions can be stopped simultaneously when the mixture is heated to release the reagent.
3. Entrapment of certain reagents affords protection from degradation during storage.
4. Some entrapped reagents are more easily and/or accurately dispensed.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure l illustrates a photograph of a 2% agarose gel, ethidium bromide stained and visualized over ultraviolet light.
This photograph demonstrates PCR products in the upper band of each lane, corresponding to 500 base pair fragments of ampli-fied Lambda DNA.
Lanes A and B show PCR products using Taq polymerase entrapped in paraffin wax and subsequently heat-released to perform the reaction. (See Example I.) Lane C shows a PCR product using the same starting solution as in A and B except Taq polymerase was added directly into the solution as a control. (See Example I.) Lanes D and E show PCR products using dNTP's entrapped in paraffin wax and subsequently heat-released to perform the reaction. (See Example II.) Lane F shows PCR a product using dNTP's entrapped in beeswax and subsequently heat-released to perform the reaction.
(See Example III.) Lanes G and H show PCR products using Taq polymerase entrapped in liposomes and also added directly into the solution. (See Example IV.) Figure 2 is a cross-sectional diagram showing a bead of molten waxy polymer (D), formed on a flat surface (E), after injection of heat-releasable reagent (B), before the injector tube (A) has been removed.
Figure 3 is a cross-sectional diagram showing a molten bead formed on a flat surface (E), by dispensing molten waxy polymer (D) from a heated dispenser tube (C). The diagram also shows an injector tube (A) leading through, and concentric with, the heated dispenser tube. Injection of heat-releasable reagent (B), has just been completed, before the tubing
- 5 assembly is removed.
Figure 4 is a cross-sectional diagram showing a molten bead formed in a cup or mold (F), by dispensing molten waxy polymer (D) from a heated dispenser tube (C). The diagram also shows an injector tube (A) in parallel and in contact with, the heated dispenser tube. Injection of heat-releasable reagent (B), has just been completed, before the tubing assembly is removed.
Figure 5 is a diagram of a device for multiple dispensing of molten waxy polymer beads and injecting them with heat-releasable reagent. The molten waxy polymer is contained in syringes (G), that are heated by heating element (H). When the dispenser plungers (I), are pushed down, melted waxy polymer beads are extruded from the dispenser tubes (C). Then, heat-releasable reagent is injected through injector tubes (A), from injector syringes (J), by pushing on injector plungers (K).
Figure 6 shows an arrangement that combines molding, packaging and subsequent dispensing of injected beads.
Injected beads (L) have been formed directly in a plastic strip of molds (M) and then covered by slipping a plastic sleeve (N) over the beads in the molds.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
For the purposes of this invention, the following defini-tions are used.
Entrapment Entrapment means enclosing a substance within an entrap-ping material to form a barrier between the outside medium and the entrapped substance.
Heat-Releasable Heat-releasable means that the entrapping material is for in vitro use and is essentially inert with the surrounding medium but can be melted, dissolved, lysed or dispersed when WO93/16200 2 1 ~ O 1 0 ~ PCT/US93/01313 exposed to the desired critical temperature. Preferred critical temperatures are above room temperature especially above 30C, the upper limit depending on the heat tolerance of the reagents used and the type of reaction employed. The entrapping material is mostly water resistant or water insolu-ble and is not readily dissolved with acids, bases, enzymes, antibodies or lytic agents. Therefore, there is little or no dissolution and release of the entrapped substance when held in an aqueous medium below the crl`tical temperature. This definition is meant to exclude the majority of entrapping materials presently used for many drug delivery systems.
Dispensable Body A dispensable body is defined as an entrapment composition that is in a mobile, particulate form (particulate entrapment), that can be readily dispersed or dispensed into a medium.
Depending on the desired application, the size of the dispens-able body may vary. When the dispensable body is formed as a small particle (i.e., less than one, to hundreds of microns in diameter), such as a granule, microcapsule, vesicle, liposome, artificial cell, filament, flake or fragment, it can be dispensed as a suspension, emulsion, colloid or slurry in a liquid medium or it can be dispensed as a free-flowing powder.
When the dispensable body is formed as a larger particle (i.e., greater than one millimeter diameter) it can be dispensed as a bead, pellet or capsule, or a coarse powder or slurry.
Entrapped Reagents An entrapped reagent is defined as any suitable substance that can be entrapped in a heat-releasable material and subsequently heated without excessive inactivation for release into a reaction.
a. Heat Resistant Enzymes: For the purposes of this invention, a heat resistant enzyme is defined as any enzyme that retains most of its activity after one hour at 40C under optimal conditions. Many such enzymes can be used such as 3~ those from thermophilic organisms. For example, various RNA
polymerases such as Q beta replicase from bacteriophage, among others, and DNA polymerases from Thermophilous sp. ("Taq"), WO 93/16200 21 ~ Q ~ 0 8 PCr/US93/01313 Thermoccocus sp. ("vent"), Thermus sp. ("Tth" and recombinant "rTth") and PYroccocus sp. ("pfu"), as well as DNA ligases such as "ampligase", from Epicentre Technologies, and any other enzymes from thermophilic microorganisms and invertebrates, including forms produced by recombinant DNA technology. Other enzymes that can be used are reverse transcriptases, restric-tion endonucleases, kinases, proteases, nucleases, RNAses, DNAses, phosphatases (i.e., alkaline phosphatases "AP"), peroxidases (i.e., horseradish peroxidase "HRP") and many others. Preferably these enzymes have sufficient thermal stable properties naturally (i.e., by isolation from thermo-philic organisms), or by suitable chemical modification, or by genetic engineering.
b. Enzyme Substrates: Another useful group of reagents for entrapment in heat-releasable reagents is any suitable substrate. For example, in the PCR, these include any labeled or unlabeled nucleotides and nucleotide triphosphates (NTP's), any deoxynucleoside triphosphates (dNTP's), any dideoxynucleos-ide triphosphates (ddNTP's) and ribonucleoside triphosphates.
Some examples are: 2'-deoxyadenosine 5'-triphosphate (dATP), 2'-deoxycytidine 5'-triphosphate (dCTP), 2'-deoxyguanosine 5'-triphosphate (dGTP), 2'-deoxythymidine 5'-triphosphate (dTTP), 2'-deoxyuridine 5'-triphosphate (dUTP), 2'-deoxyinosine 5'--triphosphate (dITP), 7-deaza-2'-deoxyguanosine 5'-triphosphate (I-N7-dGTP), among others. Also included are members of this group labeled with radioactive nuclides such as 3H, 14C, 32p, 35S, and l25I, among others.
Also included are various derivatives, analogs and labeled forms of NTP's, dNTP's and ddNTP's, such as biotin labeled, 3~ bio-4-dUTP, and bio-11-dUTP, also dNTP's labeled with digoxige-nin (DIG-UTP, DIG-dUTP, DIG-ddUTP, Biotechniques 12, 104-113 (1992)), sulfur, cyclodextrins, fluorophores, isotopes, and amino groups such as 5-(3-aminoallyl)-2'-deoxyuridine 5'-triphosphate (AA-dUTP).
c. Phosphorylated Substrates: Other substrates include any phosphorylated substrate that produces a colored, fluores-cent or chemiluminescent product when dephosphorylated, as with AP, such as 5-bromo-4-chloro-3-indoyl phosphate (BCIP) and nitro blue tetrazolium (NBT); 4-methylumbelliferyl phosphate, and any phosphorylated dioxetanes (3-(2'-spiroadamantanane)-4-methoxy-4-(3"phosphoryloxy)phenyl-l,2-dioxetane (AMPPD)) and HMPPD, among others.
d. Oxidase Substrates: Also included are any sub-strates for peroxidases such as o-phenylenediamine (OPD), 3,3'-diaminobenzidine tetrahydrochloride dihydrate (DAB), and 3,3',5,5'-tetramethylbenzidine (TMB), among others.
e. Metal Salts: Also included are various salts (i.e., chlorides or sulfates), of metals such as Mg, Mn, Fe, Co, Cu, Zn, etc.
f. Oligonucleotides: Another useful group of entrapped reagents includes any suitable RNA, DNA, and labeled or unlabeled oligonucleotides for use as hybridization probes or primers. For instance, in the PCR, any appropriate antisense (reverse) primers and sense (forward) primers can be used including those labeled with any suitable label such as biotin, AP, digoxigenin, sulfur, cyclodextrins, fluorophores, isotopes, and proteins. Also included are members of this group labeled with radioactive nuclides such as 3H, l4C, 32p, 35S, and 12sI, among others.
g. Inhibitors and Chelators: Another useful group of entrapped reagents are any enzyme inhibitors or poisons. Also included are various chelating agents such as ethylenediamine-tetraacetic acid (EDTA), ethylene glycol-bis(beta-aminoethyl ether)N,N,N',N'-tetraacetic acid (EGTA), and 2,2',2'',2'''-(l,2-ethanediylidene-tetrakis[thio])tetrakis-acetic acid (ETTA), l,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), among others.
g. Antibodies: Another useful group of entrapped reagents are any antibodies, antibody fractions or monoclonal antibodies, including derivatives thereof.
i. Antigens: Also included are any antigens, or derivatives thereof.

j. Avidins and Streptavidins: Also included are any avidins an streptavidins including derivatives, labeled forms, fractions and recombinant DNA products.
k. Biotins: Also included are any biotins, amino-biotins, photobiotins and any biotinylated proteins, nucleicacids, carbohydrates, etc.
l. Labeling substances: Also included are various labeling materials such as any isothiocyanate compounds (FITC, etc.), sulfonylchloridecompounds (4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid (BCPDA)), N-hydroxy-succinimide esters (N-hydroxysuccinimidobiotin), nucleic acid intercalating dyes (ethidium bromide, psoralens and psoralen derivatives, etc.).
The most preferred intercalating dyes are ethidium bromides, oxazole orange and thiazole orange, especially their dimers (i.e., YOYO and TOTO, Molecular Probes Inc.), trimers and various derivatives. Also included are any suitable dyes and fluorophores conjugated to and/or as inclusion complexes with cyclodextrins and any of the cyclodextrin derivatives disclosed in disclosure documents #247302, March 12, 1990;
#244763, Feb. 6, 1990; and #248131, Mar. 19, 1990. These dyes and fluorophores, including YOYO and TOTO, can be subsequently detected by fluorescence, or by a chemiluminescent reaction such as energy transfer from decomposition of certain 1,2 dioxetanes, or peroxyoxylates.
Heat-Releasable LiPosome A liposome is a rounded, submicron to many micron-sized, liquid-filled vesicle composed of a lipid bilayer membrane that completely encloses an aqueous space. The lipid bilayer may form a single membrane (unilamellar) or may form several concentric membranes (multilamellar) around the aqueous space.
The membrane may be impermeable or semipermeable depending on composition. Liposomes may be synthesized from single chain lipids or surfactant polymers, for example, see: Fendler, J., Science 223, 888-894 (1984); Hammes, G.G. et al., Biochemistry 9, 2555-2563 (1970), among others. They are generally made from mixtures of phospholipids, sterols and various amphiphilic WO93~16200 ~ PCT/US93/01313 ~3010~

lipids. A variety of proteins, enzymes, substrates, polyamino acids, nucleotides, oligonucleotides, antibodies, antigens and various reaction components can be entrapped within the membrane structure which makes certain liposomes a highly versatile tool for research and analytical applications. Also, the membrane composition can be modified through the incorpora-tion of dyes, chromophores and magnètic substances. The properties of temperature stability, fluidity, permeability and surface charge can be altered with sterols, antibiotics and charged or uncharged lipids. The liposomal membrane can also be modified by cross-linking integral lipids or surfactants, or by incorporating into the membrane a wide variety of lipids, proteins, lipoproteins and glycolipids with "activated"
functional -groups or with specific ligands coupled thereto.
For this invention, liposomes with thermal stability in the range of 30-100 degrees centigrade and with a narrow (i.e., 1-5 degrees) transition (melting) temperature range, are preferred.
Such thermal stability can be achieved by using natural or synthetic phospholipids, lipids, lecithins, surfactants, etc., that have aliphatic carbon chains of 14 or more carbons.
Many of the methods used for preparing liposomes in the prior art would be useful for preparing the liposomes of this invention. The major modifications would involve the inclusion of the desired substrate(s) or enzyme such as peroxidases, alkaline phosphatases, DNA polymerases, ligases and Q beta replicase, that is preferably heat stable, in the interior of the liposome. For examples of synthesis methods that would be useful, see: Antanavage, J. et al., BiophY. J. 21, 122a (1978); Ashcroft, R.G. et al., Biochim. Biophys. Acta 643, 191-204 (1981); Ashcroft, R.G. et al., Biochim. BioPhy. Acta 730, 231-238, (1983); Deamer, D. et al., Biochim. BioPhYs. Acta 443, 629-634 (1976); Guo, L.S.S. et al., J. Lipid Res. 21, 993-1003 (1980); Haxby, J.A. et al., Proc. Natl. Acad. Sci. USA 64, 290-295 (1969); Kinsky, S.C. et al., Biochemistry 8, 4149-4158 (1969); Kitagawa, T. et al., Nature 254, 254-256 (1975);
Reeves, J.P. et al., J. Cell. Ph~siol. 73, 49-60 (1968); Szoka, F.C. et al., Proc. Natl. Acad. Sci. USA 75, 4194-4198 (1978);

W 0 93/16200 2 l 3 a l 0 8 PC~r/US93/01313 Szoka, F. Jr., Annu. Rev. Biophys. Bioenq. 9, 467-508 (1980);
Taguchi, T., Biochim. Biophys. Acta 729, 229-236 (1983);
Takashi, T. et al., J. Biochem. 87, 679-685 (1980); Uemura, K.
et al., Biochemistry 11, 4085-4094 (1972); Uemura, K. et al., J. Immunol. Methods 53, 221-232 (1982); Van Rooijen, N. et al., Cellular Immmunol. 49, 402-407 (1980); Weissmann, G. et al., J.
- Clinical Invest. 53, 536-543 (1974); Weissmann, G. et al., Proc. Nat. Acad. Sci. USA 72, 88-92 (1975); Wreschner, D.H. et al., Biochem. Soc. Trans. 6, 930-933 (1978); Leaver, J. et al., Biochim. Bio~hys. Acta 732, 210 (1983); Mowri, H., et al., J.
Biochem. 95, 551 (1984); Mueller, P., et al., Biophys. J. 44, 375 (1983); Neitchev, V.z., Intern. J. Biochem. 16, 235 (1984);
Chapman, U.S. Pat. No. 4,348,329; and MacDonald, R.I., et al., in: LiPosome Letters, A.D. Bangham, ed., Acad. Press, N.Y.
(1983), among others.
New LiPosome Properties for Heat-Release Reactions Various materials may be incorporated into the liposome compositions disclosed to impart additional properties and thereby improve their usefulness in certain applications, especially for all of the various types of RTR's, PCR's and ligase chain reactions. For instance, the addition of suitably coated, ferrous or magnetic particles in the loading solution may be used to give the liposomes magnetic properties (Ithakissios, D.S., Clin. Chim. Acta 84(1-2), 69-84, 1978).
This may be useful for various manipulations such as dispens-ing, transferring, washing, separating or lysing the liposomes as desired before or during a thermocycling reaction. Magnetic materials may also serve to increase mixing by magnetic stirring of the solution.
Also, the liposome membrane may be modified by poly-merizing or cross-linking certain membrane lipids or dialkyl surfactants containing vinyl, methacrylate, diacetylene, isocyano or styrene coupling groups by chemical means or with ultraviolet light. The degree of cross-linking could be - 35 controlled to give the desired stability against premature lysis of, or leakage from the liposome. For more on materials and methods that are applicable to synthesizing polymerized WO 93/16200 2i3 0 ~ 8 PCT/US93/01313 liposome tracers for use in this invention, see previously cited: J.H. Fendler, Science 223, 888-894 (1984); J. Leaver, et al., Biochim. Biophys. Acta. 732, 210-218 (1983); "Polymers as Aids in Organic Chemistry", N.K. Mathur, et al., eds., Academic Press, N.Y. (1980).
Another method for stabilizing the liposomes of this invention would be to use the polymerization methods of P.S.
Ash, et al., U.S. Pat. No. 4,448,765.` To prepare the polymer-ized liposome of this invention one-l~would include the appropri-ate amount of aliphatic lipophilic polymers as disclosed byAsh, et al. as part of the vesicle membrane to obtain the desired degree of heat stability.
Another significant improvement would be to render the liposomes resistant to damage by dehydration for storage. This may be possible by using membrane stabilizers such as the disaccharide, trehalose (Crowe, J.H. et al., Science 219, 1177-1183 (1983)). For example, liposomes could be synthesized with dipalmitoyl phosphatidylcholine or other suitable lipids, included in the lipid membrane. Then, these liposomes could be dehydrated in the presence of 20% or more concentration of trehalose.
Couplinq or Cross-linking Agents: A coupling or cross-linking agent is defined here as a substance or energy, such as ultraviolet light, that produces active functional groups on an entrapment material or dispensable body such as a liposome, gel particle, artificial cell, microcapsule, or waxy polymer.
Depending on the functional group on the entrapment material, the appropriate coupling agent is used to activate the func-tional group or react with it. When the coupling agent is a substance, it may provide the linkage between the lipids, phospholipids proteins, carbohydrates or surfactants in the entrapment material. Examples of coupling agents are glutaral-dehyde, formaldehyde, cyanogen bromide, azides, p-benzoquinone, succinic anhydrides, carbodiimides, maleimides, epichloro-hydrin, periodic acid, ethyl chloroformate, dipyridyl disul-fide, polyaldehydes, dimethylsuberimidate and other forms of bis(imidoesters), as well as certain heterobifunctional WO93/16200 21 3 ~I O 8 PCT/US93/0l313 reagents such as m-maleimidobenzoyl-N-hydroxysuccinimide, N-succinimidyl-3-(2-pyridyldithio)-propionate and N-succinimidyl-(4-iodoacetyl)aminobenzoate, among others.
LiPosome EntraPped Reaqents To obtain the greatest signal per liposome, it is desir-able to have liposomes with maximal amounts of entrapped reagent such as DNA polymerase, (for the PCR) or ligase (for ligase chain reaction) and/or oligonucleotide primer, or dNTP's or other enzymes and substrates. This can be accomplished through using large, single membrane (unilamellar), vesicles.
However, multilamellar vesicles may be preferred in some cases.
Several established methods are available for liposome synthesis. These include methods that employ spontaneous swelling, sonication, ether vaporization, detergent dialysis, reverse-phase evaporation and salting-out. The reagents, etc.
can be entrapped inside the liposomes during their synthesis.
Most reagents are available from Sigma Chemical Co., Missouri, or Avanti Polar Lipids, Alabama, or can be synthesized. A
suitable method can be adapted from the methods in the litera-ture, including; Papahadjopoulos, D., R. Fraley and T. Heath, "Optimization of Liposomes as a Carrier for the Intracellular Delivery of Drugs and Macromolecules", in "Liposomes and Immunobiology", pp. 151-164, Tom/Six eds., Elsevier N. Holland, Inc. (1980); and, Szoka Jr., F., and D. Papahadjopoulos, "Procedure for Preparation of Liposomes with Large Internal Aqueous Space and High Capture by Reverse-Phase Evaporation", Proc. Natl. Acad. Sci. USA 75, 4194-4198 (1978), and many others.
Heat-Releasable Waxy Polymer Waxy or wax-like polymers are essentially water insoluble materials that are solid or semi-solid at room temperature, but can be melted above room temperature to form a dispersible liquid. Waxy polymers include any naturally occurring and synthetic waxes, wax esters, oils and greases that have the desired melting temperature and are suitably inert for use in the reaction.

W093/16200 2~3n~ PCT/US93/01313 Examples of suitable waxes and greases are esters of various long-chain (fatty) alcohols and long-chain acids, preferably where at least one member of the ester has lo or more carbon atoms, including various unsaturated and branched chain types and also those esters of glycerols and sterols.
Also, certain free alcohols or acids with even or odd numbers of carbons, have wax-like properties of melting temperature and inertness, and would be suitable as heat-releasable waxy polymers. Some examples of saturated fatty acids (and approximate melting point), that can be used in this invention are: capric (31.3C), lauric (48C), myristic (58C), palmitic (63C-64C), margaric (59.3C), stearic (70.5C-71.5C), arachidic (76OC-77C), behenic (81C-82C), tetra-cosanic (84.5C-85.5C), lignoceric (75C-80C), cerotic (78OC) , melissic (91C), among others. Some examples of unsaturated fatty acids (and approximate melting point), that can be used in this invention are: tiglic (64OC-65C), hypogaeic (33C-49C), gaidic (39C), physetoleic (30C), elaidic (44C-45C), oleic (58C-59OC), isooleic (44OC-45C), erudic (33C-34C), brassidic (65C), isoerudic (54OC-56C), among others.
Some examples of fatty alcohols (and approximate melting pointJ, that can be used in this invention are: octadecyl t59C), carnaubyl (68C-69C), ceryl (80C), melissyl (88C), phytol, among others. Also included are various esters of these and other fatty acids with any suitable fatty alcohols, or sterols such as cholesterol, or glycerols.
other examples are natural or suitably modified or derivatized waxes such as various plant derived waxes, greases and oils including carnauba wax, ouricuri wax, candelilla wax, raphia wax, apple, cotton and cactus waxes; waxes and greases produced by bacteria (i.e., cetyl stearate); fungi, protozoa and algae; various invertebrate waxes and greases including insect waxes such as beeswaxes (i.e., triacontyl palmitate, palmatyl palmitate), and Coccus sp. derived waxes (i.e., lac, cochineal and Chinese insect); other animal fats (i.e., W O 93/16200 al30iO8 PC~r/US93/01313 triglycerides) and waxes including spermaceti (i.e., cetyl palmitate), lanolin and wool grease.
Also included are various derivatives, extracts, and combinations of these materials. For instance, any oil that is suitably hydrogenated, or various new combinations of long-chain fatty acids and long-chain alcohols, usually of 12 or - more carbon atoms, to form new esters together and/or in combination with glycerols or sterols. Also included are various waxes, greases and oils produced by recombinant DNA
technology.
Other suitable waxy polymers are many natural or synthetic long chain hydrocarbons such as white waxes, paraffins, vaselines, silicon greases and waxes, polychlorinated or polyfluorinated hydrocarbons, polyether waxes and polyester waxes.
Some examples of paraffins and approximate melting point (m.p.), that can be used in this invention are; hexacosane (56.4C), octacosane (61.4C), nonacosane (62.7C), triacontane (65.6C), hentriacontane (67.6C), dotriacontane (69.5C), tetratriacontane (72.5C), pentatriacontane (74.4C), hexatria-contane (75.7C), including others with shorter or longer carbon chains.
One suitable source of paraffin waxes for use in this invention are those from Fluka Chemical Corp., St. Louis, Missoui, with m.p.'s of: 44C-46C, 50C-52OC, 54C-56C, 58C-60C, and 68C-74C.
Depending on the desired properties, such as melting point, inertness, solubility, buoyancy, etc., any of the waxy polymers described here can be combined in various proportions to give the desired result. Useful waxy polymers can also include any suitable long-chain hydrocarbon or ester mentioned previously that has been suitably derivatized to give it neutral buoyancy in an aqueous medium. For example, a long-chain hydrocarbon or ester can be suitably chlorinated or fluorinated to make it less buoyant.
Other types of polymers that can be combined with waxy polymers are polyethylenes, polypropylenes, certain gums and WO93/16200 PCTtUS93/01313 ?,i30~~ ' rubbers. Examples are various kinds of latex, gutta-percha, balata, chicle and various derivatives. Also included are synthetic rubbers such as isoprene polymers, hydrogenated rubber, butadiene polymers, chloroprene polymers and butyl polymers.
Also, suitably coated, ferrous or magnetic particles can be included in any waxy polymer to give the particles magnetic properties.
Also, under suitable conditions, the waxy polymer can have coloring added to it in the form of a colored or fluorescent dye, preferably any suitable oil or fat soluble dye can be used. Some examples are, Sudan III, Sudan IV, and Sudan Black B.
Heat-Releasable Gel A heat-releasable gel is any suitable gelling material that will form a matrix for entrapping reagents that can subsequently be melted to release the reagents when heated to a critical temperature. Examples of such gels are: agars, agaroses, carageenans, cellulose derivatives, gelatins, and alginates. Also included are suitable combinations of these gels and/or mixed with other polymers such as acrylamides, polyethylenes, styrenes, proteins, gums, latexes and resins.
PreParation Methods for Heat-Releasable Reagents A. Heat-Releasable Liposome Preparations A variety of saturated and unsaturated lipids and phospho-lipids can be used to prepare heat-releasable liposomes. Some examples are egg and soybean lecithins, dilauroylphosphatidyl choline (DLPC), dimyristoylphosphatidyl choline (DMPC), dipalmitoylphosphatidyl choline (DPPC), distearoylphosphatidyl choline (DSPC), dibehenoylphosphatidyl choline (DBPC), diarachidoylphosphatidyl choline (DAPC), any synthetic phospho-lipids with even or odd numbered, saturated or unsaturated carbon chains and their combinations, lipid esters, fatty acids, cholesterol, ceramides, cerebrosides, gangliosides, as well as derivatives with diacetylenic groups for subsequent polymerization, etc.

W O 93/16200 21 301 0 8 PC~r/US93/01313 In one example, a lipid mixture is prepared composed of DLPC dissolved in a 1:1, ethyl ether:chloroform, solvent. The concentration of total lipids can be 70-100 micromoles per ml of solvent. In mixtures of more than one lipid, the molar ratios of the lipids themselves may be varied to obtain the most suitable results.
A loading solution is prepared composed of a concentrated (0.5% or more) solution of reagent to be entrapped (i.e., enzyme or substrate) in 0.01 M suitable buffer, pH 6-8. In addition, other substances such as proteins (bovine serum albumin (BSA)), sucrose, glucose, Ficoll, polyvinylpyrroli-dones, polyethylene glycols, etc., may be included. To a 50 ml evaporation flask, is added 3 ml of the lipid mixture and 1 ml of the loading solution. The solution is sonicated to produce a homogeneous dispersion. The solvent phase is then evaporated off at a suitable temperature, while rotating at approximately 200 rpm under reduced pressure, using a water powered aspirator pump. Residual solvent is quickly removed by gel column chromatography using Sepharose 4B. The column is equilibrated with 0.01 M suitable buffer containing 0.15 M NaCl, pH 7-8, or if membrane extrusion is used, the column is equilibrated with the loading solution.
Or, suitable liposomes can be made by overlaying the loading solution over a dried layer of the desired lipid formulation in a glass dish, and allowing them to form sponta-neously at a suitable temperature.
Membrane extrusion can be used to improve size uniformity of the liposomes. Typically, this involves transferring the liposome suspension to a syringe in an excess of the original loading solution. The suspension is then forced through a narrow gauge needle or through a controlled-pore, polycarbonate membrane of 0.45-0.8 micron pore size, (Nuclepore, California).
Untrapped reagent is removed by passing the liposomes through a Sepharose 4B column equilibrated with buffer. The suspension can be concentrated by dialysis against polyethylene glycol or by centrifugation, and stored in buffer.

~3o~3~
B. Heat-Releasable Waxy Matrix PreParations One or more reagents to be entrapped are mixed directly with the melted waxy polymer. Depending on the application, the reagent can be in granular, powder or liquid form, or previously dissolved or suspended in a suitable liquid. Mixing is done by stirring, extruding or sonicating the reagent and waxy polymer together. If soluble, the reagent may dissolve into the waxy polymer, or it may~form a suspension of particles or liquid droplets or a colloid.
In any case, the melted mixture is then extruded or sprayed into particles or beads for use in subsequent reac-tions. Several suitable methods can be used, with appropriate modifications, such as spray congealing as described by A.G.
Cusimano, et al., J. Pharmaceutical Sci., 57, 1104-1112 (1968), and W.R. Marshall, Jr., Chem. Engin. Proq. Monoqr. Series 50, No. 2, Amer. Inst. Chem. Engin., New York, N.Y. (1954), among others. Basically, the method is to spray the melted mixture through a heated orifice of appropriate diameter to produce atomization, and air cool the resulting droplets so that they congeal in the air. The conditions of temperature, pressure and waxy polymer used are adjusted to ensure suitable concen-tration and activity of entrapped reagent upon release. It may be desirable to use a vibrating nozzle similar to that de-scribed by R. Nir, et al., Appl. Environ. Microb., 56, 2870-2875 (1990), to produce more uniform microspheres of entrapped reagent.
Or, the mixture is extruded to form filaments or sheets that are subsequently chopped, crushed, or ground into smaller particles.
C. Heat-Releasable Waxy Coating Preparations One or more reagents to be coated are prepared in small granules either as pure reagent or mixed with a suitable carrier substance such as a carbohydrate (i.e., glucose, sucrose, Ficoll), or any suitable gel or gel bead (i.e., agarose), protein (i.e., albumin) or polymer (i.e., polyethyl-ene glycol, acrylamide, styrene). The granules are then coated with a layer of any suitable waxy polymer using various methods W O 93/16200 2 1 3 0 1 ~ 8 P(~r/US93/01313 such as the "hot melt fluid bed coating process" described by M.J. Jozwiakowski, et al., in Pharmaceutical Res. 7, 1119-1126 ( 1990) .
For instance, the granules are fluidized in a chamber - 5 using an upward flow of warm air, and the waxy polymer is melted and sprayed into the chamber as the granules are recirculated and suitably coated.
In another method, the granules are coated by simply mixing with the melted waxy polymer. The mixture is then sprayed into a collection chamber or extruded into a cooling medium (i.e., water) to form coated granules or droplets. Or, the mixture is extruded to form filaments or sheets that are subsequently chopped, crushed, or ground into smaller parti-cles.
Another method suitable for solid particles or liquid droplets of heat-releasable reagent, is to drop the droplets through one or more moving sheets of molten waxy polymer. The sheet of waxy polymer is prepared as a continuous stream ejected under pressure from a nozzle flattened to give the desired shape. As the particles or droplets fall through the sheet of molten waxy polymer, they are coated. They are allowed to continue falling through a long enough cooling zone, such as refrigerated tower, until the waxy polymer coating has solidified. Then they are collected at the bottom on a gentle, cushioned slope to prevent damage from the fall.
Preferred Method For A WaxY Coatinq A preferred method of the instant invention for entrapping liquid heat-releasable reagents in a waxy coating is an "injected bead" method, where the desired liquid reagent is injected into a bead of molten waxy polymer, which is then allowed to cool and solidify. It has been discovered that the molten waxy polymer bead can be formed and carefully injected on a flat surface to produce liquid heat-releasable reagent coated with a waxy polymer (see Example VI~.
However, it is advantageous to form the molten bead in a small cup-like depression or mold. When the waxy polymer is dispensed into such a mold, it produces a molten bead with a 2~3~o~
curved bottom. The curvature in contact with the molten bead has the advantage of cooling the bottom into a curved form that tends to keep the injected liquid centered within the waxy polymer as it solidifies. Therefore, less care is needed when injecting the liquid heat-releasable reagent into the bead, which results in a higher percentage of suitable beads (see Example VII).
Plastic molds of various sizes to fit the desired size of injected bead, can be made from any suitable plastic, resin or polymer including acetals, polyallomers, polycarbonates, polyurethanes, polyvinyls, polyethylenes, polypropylenes, styrenes, nylons, acrylics, rubbers, polychlorinated or polyfluorinated polymers and tetrafluoroethylenes.
In addition, plastic molds of suitable thickness and flexibility have the advantage of providing a protective container bottom that can be subsequently covered for storage and/or shipping of the beads. For instance, Fig. 6 is an example of such an arrangement where injected beads (L) have been formed directly in a plastic strip of molds (M) and then covered by slipping a snug fitting plastic sleeve (N) over the beads in the molds. The mold and/or sleeve material can also be composed of suitably stiff, coated paper.
Another advantage is realized by making the molds at specific distances apart to coincide with specific reaction tube or well formats used commercially in various biochemical and enzymatic assays such as ELISA's, and the PCR. For example, molds such as that shown in Fig. 6, would be made at 9 mm center spacing and in strips of 4, 8 or 12, so that they are compatible in spacing with the conventional 96 well microtiter plate format. Or, an entire plate format of 96 molds at 9 mm center spacing can be used.
These features make the use of molds for injected beads very advantageous for selling the beads in mercantile kits.
For example, beads would be formed directly in suitable polyvinyl or polystyrene molds where the above described strips or plates are covered with a plastic sheet or slipped into a suitable plastic sleeve to form packages which would minimize WO93/16200 2 1 3 0 1 0 ~ PCT/US93/01313 -handling. Plastic molds would also be useful in dispensing the beads by removing the cover on individual beads or from an entire strip or plate and simply dumping out, or pushing the beads out of a flexible mold from the back over each well or tube. If rigid molding is used, then small holes could be made in the bottoms of each well to allow the beads to be pushed out mechanically or by air pressure.
The injected bead method, with or without using molds, is readily adapted to automated or semi-automated methods. For instance, a series of dispensing devices for the molten waxy polymer (i.e., heated syringes and tubing), can be arranged to dispense a row of several molten beads simultaneously. The molten beads can then be injected with heat-releasable reagent by a corresponding row of injecting devices (syringes). After injection, the beads are moved out of the way for a new set of beads to be made. All of the necessary steps can be automated or semi-automated. For instance, precision drivers such as electronically controlled step motors can be used to turn screws that push syringe plungers to dispense the molten waxy polymer and inject the heat-releasable reagent.
Preferably, the heated tube from the waxy polymer dispens-er and the tube from the heat-releasable reagent injector lead to the same point. This way, the tip of the injector tube is also heated and is in the proper position to inject right after ~5 the molten waxy polymer bead is dispensed. The dispenser and injector tips can be fastened together in parallel, or the injector tip can be suitably threaded a short distance inside the end of the dispenser tube to give concentric tubes.
D. Heat-Releasable Gel Matrix Preparations One or more reagents to be entrapped are mixed directly with the melted gel. The melted mixture is then extruded or sprayed into particles or beads for use in subsequent reac-tions. Several suitable methods can be used, with appropriate modifications, such as spray congealing as described previously for waxy polymers.

W093/16200 2~3~~ PCT/US93/01313 Or, the melted gel with reagent can be extruded into a cooling medium (i.e., water or oil) to form granules, micro-beads or droplets.
A preferred method is to use a gel matrix preparation in the drop bead or injected bead method. For instance, beads, microbeads, or droplets of solidified gel (i.e., 0.2-1% low m.p. agarose), are prepared containing heat-releasable reagent and suitable amounts of other additives such as sucrose, Ficoll or BSA to increase density as needed. Then, the gel beads are dropped through a molten layer of waxy polymer to form "drop beads" as described herein. The resulting product is a gel bead with a waxy polymer coating that can be melted to release the reagents inside.
Or, a suitable mixture of melted gel and heat-releasable reagents can be injected into molten waxy polymer beads as described in Examples VI or VII.
E. Heat-Releasable Gel Coating PreParations One or more reagents to be coated are prepared in small granules either as pure reagent or mixed with a suitable carrier substance such as a carbohydrate (i.e., glucose, sucrose, Ficoll), or any suitable gel or gel bead (i.e., agarose), protein (i.e., albumin) or polymer (i.e., polyethyl-ene glycol, acrylamide, styrene). The granules are then coated with a layer of any suitable melted gel material using various methods such as the "hot melt fluid bed coating process"
described previously.
In another method, the granules are coated by simply mixing with the melted gel. The mixture is then sprayed into a collection chamber or extruded into a cooling medium (i.e., water or oil) to form coated granules or droplets.
F. Heat-Releasable Microcapsule Preparations Useful heat-releasable reagents can also be prepared by entrapment of reagents inside microcapsules that are essential-ly water insoluble and will melt when heated to the desired temperature. The synthesis would involve polymers that are not so cross-linked that they cannot melt, and may include water WO93/16200 2~ 3 0 1 0 8 PCT/US93/01313 proof or water resistant additives in the surface or coated on the outside.
G. Mercantile Kits for Heat-Releasable PreParations A mercantile kit is defined as a collection of materials - 5 such as containers (such as in Fig. 6), reagents, buffer solutions, instructions for use, packaging, and the like, prepared as a package for sale. Any of the heat-releasable reagents disclosed in the instant invention can readily be incorporated into a mercantile kit.
The following applications illustrate the great diversity of uses for the instant invention. With suitable modification by one skilled in the art, the heat-releasable reagents of this invention can be applied to any of the following applications.
Application A.
PCR Usinq Heat-Releasable DNA PolYmerase Reagent The DNA sample to be amplified is in a final volume of 0.02-O.l ml containing: 0.5 mM each of dATP, dCTP, dGTP, and dTTP (or any other suitable labeled or unlabeled dNTP's), 0.002 mM each of any appropriate antisense (reverse) primers and sense (forward) primers, in a buffer of 2.5 mM MgCl2, 500 mM
KCl, lO0 mM Tris-HCl, 0.1% w/v gelatin, pH 8.3.
Also included is any heat stable DNA polymerase entrapped as a heat-releasable reagent as described previously. In this case, approximately l unit of Taq DNA polymerase entrapped in waxy polymer particles or in liposomes that melt at a specific temperature (preferred range 50C-100C), is added. The PCR
reaction is initiated when the heat-releasable DNA polymerase reagent is melted to release the polymerase into solution.
Amplification is performed by sequential immersion in water baths or in any suitable thermal cycling machine. A "hot start" method is initiated when the sample is heated to the critical releasing temperature of the heat-releasable reagent.
Samples are optionally denatured at 98C for 30 seconds followed by 20-40 cycles of: 94C for 20-60 seconds, 65C for 20-60 seconds, 72C for 60-120 seconds.

~,~3~
Application B.
PCR Using Heat-Releasable Substrate Reagent This example is similar to the method using heat-releas-able DNA polymerase reagent except that another reagent is entrapped for heat release besides or instead of the enzyme.
In this case, the appropriate dNTP's entrapped in waxy polymer particles or in liposomes that melt at a specific temperature (preferred range 50C-100C), are added instead of dNTP's free in solution. The PCR reaction is initiated when the heat-releasable dNTP reagent is melted to release them into solution.
Or, some dNTP's can be in the solution initially, while certain others, such as any labeled dNTP's are entrapped for release after the desired number of cycles. This is done by having the labeled dNTP's in a high melting point heat-releas-able reagent such as 95C-100C. The initial cycles of PCR are kept below that melting point. When they are needed in the reaction, the temperature is raised to release them.
Application C.
Hiqh TemPerature RTR
The instant invention is useful in high temperature reverse transcriptase reactions such those reported by A.L.
Schaffer, et al., Anal. Biochem. 190, 292-296 (1990) and T.W.
Myers, et al., Biochem. 30, 7661-7666 (1991). The procedure is modified in that one or more essential reagents, such as Taq DNA polymerase, or Tth DNA polymerase, or dNTP's, are first entrapped in a heat-releasable reagent that melts at or near the desired reaction temperature (i.e., 70C). Then, the reaction will not be initiated until it has reached the desired temperature and the reagent(s) are released. The high tempera-ture RTR is reported to improve product specificity and destabilize many secondary structures in the template RNA, to allow more complete transcription.
Application D.
Hiqh TemPerature Nucleic Acid Seguencinq This method is based on the procedures of F. Sanger, et al., Proc. Natl. Acad. Sci. USA 74, 5463-5467 (1977), S. Tabor, W093/16200 213 ~ 1 0 8 PCT/US93/Ot313 et al., Proc. Natl. Acad. Sci. USA 84, 4767-4771 (1987) and M.A. Innis, et al., Proc. Natl. Acad. Sci. USA 85, 9436-9440 (1988). This method utilizes the three basic steps of anneal-ing, labeling and extension/termination used in previous - 5 dideoxynucleotide methods (Sanger) except that the need for reopening and transferring of reaction products is reduced.
For instance, the annealing and labeling reactions can be combined by preparing the template DNA in a mixture with the needed primer(s), Taq DNA polymerase and labeling mixture of dNTP's. However, before addition, the Taq and dNTP's are first entrapped in a heat-releasable reagent that melts at 80C-95C.
Then, the entrapped reagents are not available until the template has been fully denatured (i.e., 80C-95C).
Application E.
Coupled Hiqh TemPerature RTR and PCR
It has been reported by T.W. Myers, et al., Biochem. 30, 7661-7666 (1991) and W.T. Tse, et al., Gene 88, 293-296 (1990), that the reverse transcription reaction to make cDNA from RNA
and the polymerase chain reaction to amplify the cDNA, can be coupled. The heat-releasable reagents of this invention are useful in reducing the steps normally required. For example, all of the necessary reagents for running the coupled RTR/PCR
reaction of Myers, using Tth polymerase, can be combined in a single tube. The modification is that the required amounts of EGTA, MgCl2 and the forward and reverse PCR primers are entrapped in heat-releasable reagents (together or separately), that melt the desired temperature (i.e., 80C-95C).
The RTR reaction is run at 70C under the required conditions in a thermocycling machine. Then, without opening the reaction container, the PCR is initiated by raising the temperature to melt and release the entrapped reagents. The required cycle parameters are then used to complete the PCR.
Application F.
Booster PCR With or Without Hot Start This application is based on the methods of G. Ruano, et al., Nucleic Acids Res. 17, 5407 (1989), and G. Ruano, et al., Proc. Natl. Acad. Sci. USA 87, 6296-6300 (1990). This method 2~3~o~
is based on the idea of using a very low concentration of PCR
primers for the first few cycles of PCR to increase specific product, and then boosting the concentration later.
The heat-releasable reagents of this invention are useful in this application. For example, a predetermined concentra-tion of PCR primers "A and B" is entrapped in a heat-releasable reagent to melt at a predetermined temperature (i.e., 96C-100C). A reaction mixture is prepared with the target nucleic acid, any heat stable DNA polymerase, a suitably low concentra-tion of the same PCR primers, A and B, and all other reagents needed for the reaction. Then, the sample is thermally cycled a few times under standard PCR conditions except the tempera-ture is kept below the melting temperature of the entrapped primers (i.e., 90C-92C). After sufficient early cycles, the temperature is raised to melt the heat-releasable primer reagent and the PCR is continued as desired.
Alternatively, a "hot start" feature can be included by leaving the polymerase out of the initial reaction mixture.
Instead, the polymerase to be used is entrapped in a second heat-releasable reagent that melts at a lower temperature (i.e., 70C-90C), than the entrapped primers. In this case, the PCR is only initiated when the entrapped polymerase is released and the same procedure is used.
Application G.
Nested PCR
Nested PCR is another scheme for increasing the specifici-ty of target DNA amplification, described by K.B. Mullis, et al., Methods Enzvmol. 155, 335 (1987) and H.A. Erlich et al., Science 252, 1643-1651 (1991), among others. The strategy is to use one set of "outer" primers to initially amplify a segment of DNA that includes the target sequence, then add a second set of "inner" primers to specifically amplify the target sequence in the product the outer primers amplified. In the prior art, this has been done either by stopping the reaction to add the second set of primers, or by designing primers with certain sequences that effect their melting temperature (i.e., GC rich for high, AT rich for low).

However, these problems can be avoided by using the heat-releasable reagents of this invention.
For example, a predetermined concentration of inner PCR
primers "C and D" is entrapped in a heat-releasable reagent to - 5 melt at a predetermined temperature (i.e., 96C-100C). A
reaction mixture is prepared with all the reagents needed for the reaction: the target nucleic acid, any heat stable DNA
polymerase, and a suitably low concentration of outer PCR
primers, A and B.
Then, the sample is thermally cycled a few times under standard PCR conditions, except the temperature is kept below the melting temperature of the entrapped inner primers (i.e., 90C-92C). After sufficient early cycles (preferably to consume most of the outer primers A and B), the temperature is raised to melt the heat-releasable reagent with the inner primers C and D. The PCR is continued as desired, to preferen-tially amplify the inner target sequence.
Alternatively, a "hot start" feature can be included by leaving the polymerase out of the initial reaction mixture.
Instead, the polymerase to be used is entrapped in a second heat-releasable reagent that melts at a lower temperature (i.e., 70C-9OC), than the entrapped primers. In this case, the PCR is only initiated when the entrapped polymerase is released and the same procedure is used.
Application H.
Other TyPes of PCR
With suitable modification by one skilled in the art, the heat-releasable reagents of this invention can be applied to a wide variety of PCR methods. These include asymmetric PCR, inverse PCR and arbitrarily primed PCR (APPCR), among others.
For example, this invention is readily adapted for use in in situ PCR, described by G.J. Nuovo, et al., Amer. J. Pathol.
139, 847-854 and 1239-1244 (l991).
The reagents of this invention are also applicable to - 35 inverted PCR (IPCR) as described by S. Takagi, et al., in Biotechniques 13, 176-178 (1992), and especially heat-soaked PCR (HS-PCR), as described by G. Ruano, et al., in WO9~"~ PCT/US93/01313 Biotechniques 13, 266-274 (1992), but suitably modified so that a bolus of reagent would be added in a heat-releasable composi-tion of this invention such as a waxy polymer bead.
Application I.
Nucleic Acid Hybridizations The heat-releasable reagents of this invention are useful in increasing specificity durin~ certain nucleic acid hybrid-izations. For example, the labeled oligonucleotide probe is entrapped in any suitable heat-releasable reagent and added to the sample (i.e., nucleic acid immobilized to a membrane or to the inside surface of a container). The sample is heated to the desired temperature to melt the heat-releasable reagent and the probe becomes available for hybridization to the sample.
After a suitable period, the unhybridized probe is washed away and the sample is handled by standard methods. The heat-releasable reagents of this invention can be utilized in a wide variety of hybridization procedures including in situ and "sandwich'l hybridization, among others, and include any type of labeled probe, as described by M.S. Urdea, et al., Nucleic Acids Res. 16, 4937-4956 (1988), and others.
Application J.
Alkaline Phosphatase Label Detection Usinq Heat-Releasable Substrate Reaqent In this example alkaline phosphatase (AP) is used for a label on any conventional specific binding substance such as a DNA, RNA or oligonucleotide probe, PCR primer, avidin or streptavidin, antibody, or antigen, among others. After the AP-labeled substance has been used in the appropriate binding reaction such as hybridization to complementary DNA or an antigen-antibody (i.e., ELISA) reaction, the bound substance is separated from the unbound. Separation can be done by binding to a solid support such as a membrane or the surface of a tube or well (i.e., sandwich immunoassay), or separation is done by various precipitation reactions.
In any case, the presence of the AP label is detected by first immersing the enzyme in a suitable buffer such as AP
buffer composed of 0.1 _ Tris HCl, 0.2 M NaCl, 0.01 M MgCl2, pH

WO93/16200 Zl 3 ~1 0 8 PCT/US93/01313 9.5-l0. Then, a heat-releasable substrate reagent is added either with the AP buffer or afterwards. In this case, the heat-releasable reagent is concentrated substrate entrapped in any suitable waxy polymer or liposome that will melt at 40C-60C. The substrate is a mixture of 5-bromo-4-chloro-3-indoyl phosphate (BCIP) and nitro blue tetrazolium (NBT).
When the sample is heated briefly to the melting tempera-ture, the substrates are released to give approximately 0.17 mg/ml BCIP and 0.33 mg/ml NBT. The sample is incubated at a lower temperature to produce a colored product that is measured by absorption.
Application K.
Peroxidase Label Detection Using Heat-Releasable Substrate Reagent This example is similar to the hybridization and immunoas-say methods for AP detection except that the label is any suitable peroxidase such as horseradish peroxidase, and the buffer is more acidic such as 0.l M sodium citrate, pH 5Ø
In this case, the heat-releasable reagent is concentrated o-phenylenediamine (OPD) entrapped in any suitable waxy polymer or liposome that will melt at 40C-60C. When the sample is heated briefly to the melting temperature, the substrate is released to give approximately 0.l % OPD. The sample is incubated at a lower temperature to produce a colored product that is measured by absorption at 490 nM.
The following examples show the use of this invention in the PCR, which is one of several possible applications.

EXAMPLE I
Heat-Releasable Taq DNA Polymerase Reagent Entrapped in Paraffin Wax In this example, 0.0l ml of aqueous buffer containing 50 units of Taq DNA polymerase (Boehringer Mannheim Corp., Indianapolis, Indiana), was mixed with 0.l gm of finely ground sucrose. The pH 8.0 buffer also contained 20 m_ Tris-HCl, l m_ dithiothreitol, 0.l mM EDTA, 0.l m KCl, 0.5% Thesit, 0.2 mg/ml gelatine and 50% (v/v) glycerol. The solution may also include ~3~o~
Mg2+ as MgCl2, and approximately 0.05-0.1% bromophenol blue.
The mixture is partially dried to form small loose grains and mixed with approximately 0.5 gm of melted paraffin wax (64C).
With the grains evenly distributed within, the melted wax mixture was cooled and solidified t~o form a flat disk approxi-mately 2.5 cm diameter. Using a sharp blade, excess wax was trimmed from the edges and the disk was cut into approximately 2 mm diameter, dispensable particles that were washed by shaking in about 20 ml of water and soaked 20 minutes in a fresh volume of water. The particles were collected on absorbent paper, dried at room temperature and weighed.
The amount of particles to use in a particular reaction is calculated from the amount of polymerase in the total weight.
In this example, there were 5 units of enzyme in a total weight of 0.32 gm. To use 1 unit of the entrapped enzyme, a 1/50 fraction is needed, or approximately 0.0064 gm of particles.
The entrapped DNA polymerase reagent was tested in the PCR
using commercially available "PCR buffer" (Boehringer Mannheim). The DNA (template) to be amplified was Lambda bacteriophage DNA from Sigma Chemical Corp. St. Louis, Missou-ri. The 25 base oligonucleotide primers were "Lambda control primers" #1 and #2 (Perkin-Elmer Cetus, Norwalk, Connecticut), which complement the ends of a 500 base pair segment on the Lambda DNA, nucleotides 7131 through 7630.
A PCR "master mix" was prepared in PCR buffer without DNA
polymerase, to give 4 mm MgCl2, 0.4 mM each of dATP, dCTP, dGTP, and dTTP (dNTP's), 0.002 micrograms of Lambda DNA, 2 microliters (0.04 nanomoles) of each primer #1 and #2 for each reaction volume of 0.05 ml. After dispensing 0.05 ml of master mix into each of three sample containers, DNA polymerase was added as follows:
Sample A received 0.012 gm (2 units), and sample B
received 0.024 gm (4 units), of paraffin entrapped Taq DNA
polymerase reagent. Sample C received 1 unit of standard un-entrapped Taq DNA polymerase as a control. The samples werethermocycled for 30 cycles of: 30 seconds @ 94C, 30 seconds @
40C, and 60 seconds @ 72C.

WO93/16200 2 1 ~ O 1 0 8 PCT/US93/01313 The PCR products were analyzed by a standard method of agarose gel electrophoresis (AGE). The samples A, B and C were loaded into corresponding wells A, B and C. The AGE was done horizontally using 2% agarose gel and 89 mM tris, 89 mM borate, 2 mM EDTA (TBE) buffer (pH 8), containing 0.5 micrograms/ml of ethidium bromide stain. The gel was run for l hour at 100 volts and 50 milliamps, then subilluminated with U.V. light and photographed with Polaroid instant film.
AGE analysis of PCR samples with master mix alone gives no visible product (data not shown). However, as is shown in Fig.
1, lanes A, B and C, visible product bands can be seen at the top of each lane. These results indicate that the paraffin entrapped Taq DNA polymerase reagent in samples A and B was released from entrapment during the PCR and successfully amplified the Lambda DNA compared to control C.
AGE Method For Sam~les In A 96 Well Format Higher numbers of samples can be analyzed when loaded directly from the PCR tubes into the agarose gel for electro-phoresis. It has been discovered that this is greatly facili-tated by using specially designed combs for making the samplewells in the gel. As described in Disclosure Document number 291836, the key feature is that the combs were made with teeth that are spaced with 4.5 mm centers. This spacing is one half the normal 96 well or microtiter format (9 mm centers), found in PCR thermocyclers such as the Perkin Elmer Model 9600 and the microplate cyclers sold by Techne Corp. and MJResearch, Massachusetts. Typically, combs are used that are 1-3 mm thick with teeth cut 2.5 mm wide, leaving 2 mm spaces between.
However, other teeth dimensions that fit within the 4.5 mm center to center requirement would be suitable. Also, the combs can be made of any suitable plastic commonly used for AGE, as well as other materials used for special applications.
The resulting wells formed at 4.5 mm centers provide twice as many wells as there are microwell samples, in the same distance. Solutions are conveniently transferred from the microwells and loaded into the gel wells with the use of a standard multichannel pipettor (i.e., Labsystems, Massachu-WO 93/16200 ~,30~ ~1 PCI/US93/01313 setts, or Brinkmann Instruments, Inc., New York). However, this method works best when a pair of rows of microwell (9 mm spacing), samples are both loaded into the same gel row using alternate wells.
For instance, microwell samples of:
A1 A2 A3 A4 A5 A6 A7 A8 etc.
B1 B2 B3 B4 BS B6 B7 B8 etc.
transferred to alternate wells in one row of the gel give:
A1 B1 A2 B2 A3 B3 A4 B4 A5 B5 A6 B6 A7 B7 A8 B8 etc.
The result is that twice as many samples can be run in the gel, which saves space and use of the gel.
Also, the 4.5 mm spacing format can easily be adapted for use in other electrophoresis methods. For instance, in vertical acrylamide gels that employ "shark~s tooth" combs, the teeth would be made at 4.5 mm centers. This format can also be applied to capillary electrophoresis by arranging the electro-phoresis sampling cups with 4.5 mm spacing and/or the capillary tubes themselves at 4.5 mm spacing.

EXANP~E II
Heat-Releasable dNTP Reaqent Usinq a Paraffin Wax Coatinq In this example, 0.02 ml of water containing 25 mM each of dATP, dCTP, dGTP and dTTP, is mixed with 0.1 gm of finely ground sucrose. The solution may also include an equimolar amount of Mg2+ as MgCl2, and approximately 0.05-0.1% bromophenol blue. The mixture is dried to form small loose grains and mixed with approximately 0.5 gm of melted paraffin wax (64C).
With the grains evenly distributed within, the melted wax mixture was cooled and solidified to form a flat disk approxi-mately 2.5 cm diameter. Using a sharp blade, the disk was cut into approximately 2 mm diameter particles that were washed by shaking in about 20 ml of water and soaked 20 minutes in a fresh volume of water. The particles were collected on absorbent paper, dried at room temperature and weighed.
The amount of particles to use in a particular reaction is calculated from the amount of dNTP's in the total weight. In this example, there was 0.5 micromoles of each dNTP in a total WO93/16200 ~1 30108 PCT/US93/01313 weight of 0.546 gm. To use 0.02 micromoles of the entrapped dNTP, a l/25 fraction is needed, or approximately 0.022 gm of particles.
The entrapped dNTP reagent was tested in the PCR using commercially available "PCR buffer" (Boehringer Mannheim Corp., Indiana). The DNA (template) to be amplified was Lambda bacteriophage DNA from Sigma Chemical Corp. The 25 base oligonucleotide primers were "Lambda control primers" #l and #2 (Perkin-Elmer Cetus, Connecticut), which complement the ends of lOa 500 base pair segment on the Lambda DNA, nucleotides 7131 through 7630.
A PCR "master mix" was prepared in PCR buffer without any dNTP's, to give l unit Taq DNA polymerase, 4 mm MgCl2, 0.002 micrograms of Lambda DNA, 2 microliters (0.04 nanomoles) of 15each primer #l and #2 for each reaction volume of 0.05 ml.
After dispensing 0.05 ml of master mix into each of two sample containers, dNTP's were added as follows:
Sample D received O.Ol gm, and sample E received 0.02 gm of paraffin entrapped dNTP reagent. The samples were thermo-20cycled for 30 cycles of: 30 seconds @ 94C, 30 seconds @ 40C, and 60 seconds Q 72C. The PCR products were analyzed by a standard method of agarose gel electrophoresis (AGE). The samples D and E were loaded into corresponding wells D and E.
The AGE was done horizontally using 2% agarose gel and TBE
25buffer containing 0.5 micrograms/ml of ethidium bromide stain as in Example I. The gel was run for l hour at lO0 volts and 50 milliamps, then subilluminated with U.V. light and photo-graphed with Polaroid instant film.
As is shown in Fig. l, visible product bands can be seen 30at the top of lanes D and E. These results indicate that the paraffin entrapped dNTP reagent in samples D and E was released from entrapment during the PCR and was successfully used as a substrate to amplify the Lambda DNA.

W O 93/16200 PC~r/US93/01313 ~ ~3 ~ ~ EXAMPLE III
Heat-R~eleasable dNTP Reaqent Usinq Beeswax Coated Pellets In this example, 0.02 ml of water containing 25 mM each of dATP, dCTP, dGTP and dTTP, is mixed with 0.1 gm of finely ground sucrose. The solution may also include an equimolar amount of Mg2+ as MgCl2, and approximately 0.05-0.1% bromophenol blue. The mixture is dried to form small loose grains and mixed with approximately 0.5 gm of melted beeswax (80C). With the grains pushed out of the center to form a circle, the melted wax mixture was cooled and solidified to form a flat disk approximately 2.5 cm diameter. Using a sharp blade, the disk was trimmed of wax without entrapped grains and cut into pellets of approximately 1 x 2 x 4 mm that were washed by shaking in about 20 ml of water and soaked 20 minutes in a fresh volume of water. The pellets were collected on absorbent paper, dried at room temperature and weighed.
The number of pellets to use in a particular reaction is calculated from the amount of dNTP's in the total number of equal sized pellets. In this example, there was 0.5 micromoles of each dNTP in a total weight of 0.418 gm. The average pellet weight was 0.011 gm., which is approximately 0.013 micromoles of the entrapped dNTP per pellet.
The entrapped dNTP reagent was tested in the PCR using commercially available "PCR buffer" (Boehringer Mannheim Corp., Indiana). The DNA (template) to be amplified was Lambda bacteriophage DNA from Sigma Chemical Corp. The 25 base oligonucleotide primers were "Lambda control primers" #1 and #2 (Perkin-Elmer Cetus, Connecticut), which complement the ends of a S00 base pair segment on the Lambda DNA, nucleotides 7131 through 7630.
A PCR "master mix" was prepared in PCR buffer without any dNTP's, to give 1 unit Taq DNA polymerase, 4 mm MgCl2, 0.002 micrograms of Lambda DNA, 2 microliters (0.04 nanomoles) of each primer #l and #2 for each reaction volume of 0.05 ml.
After dispensing 0.05 ml of master mix into the sample contain-er, sample F received 1 pellet of beeswax entrapped dNTP
reagent.

WO93/16200 2 I 3 ~1 0 8 PCT/US93/01313 The sample was thermocycled for 30 cycles of: 30 seconds @ 94C, 30 seconds @ 40C, and 60 seconds @ 72C.
The PCR product was analyzed by a standard method of agarose gel electrophoresis (AGE). Sample F was loaded into 5corresponding well F.
The AGE was done horizontally using 2% agarose gel and TBE
buffer containing 0.5 micrograms/ml of ethidium bromide stain as in Example I. The gel was run for l hour at lO0 volts and 50 milliamps, then subilluminated with U.V. light and photo-lOgraphed with Polaroid instant film.
As is shown in Fig. l, a faint but visible product band can be seen at the top of lane F. These results indicate that the beeswax entrapped dNTP reagent in samples F was released from entrapment during the PCR and was successfully used as a 15substrate to amplify the Lambda DNA.

EXAMPLE IV
PCR With Liposomes and Taq DNA Polymerase Liposomes with entrapped Taq DNA polymerase were prepared 20by first evaporating a lipid mixture containing 0.2 ml of 0.078 gm/ml soybean lecithin and 0.05 ml of 0.074 gm/ml cholesterol, on one half of the inside wall of a glass vial (22 mm diameter x 45 mm high), held on its side. To the dried lipid layer was added 0.08 ml of 0.02% bromophenol blue in Hank's balanced salt 25solution (HBSS) and 0.02 ml of Taq buffer containing lO0 units of Taq DNA polymerase (Boehringer Mannheim Corp., Indiana).
The Taq buffer also contained 20 mM Tris-HCl, l mM dithiothrei-tol, O.l mM EDTA, O.l mM KCl, 0.5% Thesit, 0.2 mg/ml gelatine and 50% (v/v) glycerol. Liposomes were allowed to form as the 30vial was gently rolled on its side for 5-lO minutes. The turbid solution was forced back and forth through an Eppendorf pipette tip 8-lO times and centrifuged to pellet the liposomes.
The liposomes were washed twice by resuspending in l.5 ml HBSS
and centrifuging as before, finally resuspending them in 0.012 ml HBSS.
The liposome entrapped DNA polymerase reagent was tested in the PCR using commercially available "PCR buffer"

W093/t6200 PCT/US93/01313 ~3~o~
(Boehringer Mannheim). The DNA (template) to be amplified was Lambda bacteriophage DNA from Sigma Chemical Corp., Missouri.
The 25 base oligonucleotide primers were "Lambda control primers" #1 and #2 (Perkin-Elmer Cetus, Connecticut), which complement the ends of a 500 base pair segment on the Lambda DNA, nucleotides 7131 through~7630.
A PCR "master mix" was prepared in PCR buffer without DNA
polymerase, to give 4 mm MgCl2, 0.4 mM each of dATP, dCTP, dGTP, and dTTP (dNTP's), 0.002 micrograms of Lambda DNA, 2 microliters (0.04 nanomoles) of each primer #1 and #2 for each reaction volume of 0.05 ml. After dispensing 0.05 ml of master mix into each of two sample containers, liposome entrapped DNA
polymerase was added as follows:
Sample G received 3 microliters and sample H received 9 microliters, of the liposome entrapped Taq DNA polymerase suspension. The samples were thermocycled for 30 cycles of: 30 seconds @ 94C, 30 seconds @ 40C, and 60 seconds @ 72C. The PCR products were analyzed by a standard method of agarose gel electrophoresis (AGE). The samples G and H were loaded into corresponding wells G and H.
The AGE was done horizontally using 2% agarose gel and TBE
buffer containing 0.5 micrograms/ml of ethidium bromide stain as in Example I. The gel was run for 1 hour at 100 volts and 50 milliamps, then subilluminated with U.V. light and photo-graphed with Polaroid instant film.
No visible product was detected (data not shown).
To each sample G and H, was added 4 units of un-entrapped Taq DNA polymerase, the PCR cycles were repeated and the samples again analyzed by AGE as before.
As is shown in Fig. 1, visible product bands can be seen at the top of lanes G and H. These results indicate that soybean lecithin and cholesterol liposomes are usable in the PCR.

WO93/16200 2 l 3 0 1 ~ ~ PCT/US93/01313 EXAMPLE V
Waxy PolYmer Coated Drop Beads Made by DropPing Them Throuqh Melted Wax In this example, waxy coated liquid droplets, called "drop beads", were made by dropping liquid through melted wax.
Approximately 3 microliter sized droplets of heat-releasable reagent were dropped through a thin molten waxy polymer layer on the surface of a water bath and were instantly coated after passing through the wax layer and sinking to the bottom. The resulting wax coated beads were spherical and had very thin wax shells, with diameters of approximately 3-4 mm.
A tall glass beaker (top diameter 6.7 cm, height 14 cm), was filled to the top with distilled water, and placed in a 1 L beaker partially filled with water. After the two water levels were evened, a submersible heater was used in the outer bath to heat the top 6-7 cm of the outer and inner baths to boiling (94C-95C). A temperature gradient was achieved by submersing the lower 5-6 cm of the entire beaker assembly in an ice bath. A 7-10 cm deep heat zone was formed that ranged from 95C at the top to 75 C at the bottom. Below the heat zone, (approx. 4 cm remaining) it was 40C-15C. After the system was equilibrated, one gram of paraffin wax (m.p. 68-74 C, Fluka Chemical Corp.), was added to the inner bath and gently stirred until the wax melted and formed a uniformly thick "puddle" over the entire surface.
The dropping solution consisted of heat-releasable reagent (horseradish peroxidase enzyme, 1 unit/microliter of phosphate buffer) in a 2:1 sucrose solution (2 g sucrose/ 1 g distilled water) with a suitable amount (1 drop/lo ml) of commercial food coloring. The color was useful in showing that the dropping solution was being entrapped in the drop beads and also helped in showing possible imperfections in the wax coating.
Small droplets were formed using a 30-35 gauge plastic tubing ~i.e., gel loading pipet tips work well) attached to a 3S 1 ml syringe. With the syringe held vertically, droplets were released 8-9 cm above the center zone (3-4 cm diameter) of the wax layer, every 5-6 seconds. After 50 beads were made the wax W O 93/16200 PC~r/US93/01313 '1~3~~
layer was replenished by adding 0.14 g of new wax (approx.
0.0028 gm wax consumed/bead). The dropping solution was maintained at room temperature.
An oil layer covering the outer bath surface helped reduce evaporation and the two levels were held constant for several hours. This helped keep temperatures in the inner bath constant. A lower water level in the outside beaker changes the heating zone for the inside bath and this should be avoided. For example, a cooler temperature around the wax puddle usually resulted in droplets sticking if the droplet densities or dropping heights were not increased.
After about 150 drop beads were made the system was allowed to cool and the beads were removed by pouring them out into a paper or polypropylene filter. The beads were then washed several times with distilled water and then brushed out onto a paper towel to dry.
The beads were tested for total volume by puncturing the bead and drawing the contents into a precalibrated 10 microli-ter capillary pipet (Drummond). Beads typically contained an average volume of 2.6 microliters.
The average amount of wax in each bead was calculated from the weight of washed and dried wax from 5-10 beads. The average amount of wax per bead was typically 2.8 mg.
Many parameters such as dropping height, dropping solution density vs. droplet size, temperature, and wax puddle thickness effect drop bead formation. These parameters all effect how well the droplets punch through the puddle and the quality of the coatings that result. Dropping heights that are too high generally cause bubbles at the tops of the beads which expand as the newly formed beads sink and the beads ultimately rise again to remelt. High dropping solution densities are general-ly better (i.e., using sucrose:water at greater than 2:1 ratio), because the droplets easily punch through the puddle.
Puddle thickness and dropping height also effect the ability of the droplet to punch through and temperature effects the strength of the wax (high temperature makes the wax more fluid). Puddles that are too thin generally result in incomplete coating. To make drop beads consistently, all of these parameters are optimized because they are interdependent.
Waxy polymer drop beads have been made using many differ-ent sized containers and heating devices. Deeper baths were used to vary the heat zone depth and in some cases deeper heat zones were necessary to completely seal the wax coating on larger beads (10-50 microliters). Larger diameter wax puddles increased the number of beads that could be made in a batch without replenishing wax.
Double Coated Drop Beads Thicker coatings can readily be applied to the drop beads with "double dipping". This was done by dropping waxy polymer beads through another molten paraffin wax layer. The second wax layer was a lower melting point wax (i.e., 5C-10C lower).
This allowed for the temperature of the bath to be lowered and the first layer of wax on the bead would remain solid.
Multiple layers of wax can be applied by dropping or dipping beads into molten wax at slightly lower temperatures than the melting point of the previous wax used.
Testinq Drop Beads Drop beads were tested for encapsulation of horseradish peroxidase (HRP) enzyme. In this example the permeability of double coated beads was compared with single coated beads. The general procedure was to make drop beads using the method described previously where the dropping solution contained 1 unit per microliter concentration of enzyme in a 2:1 sugar solution. After the beads were rinsed and dried, 36 of the single coated beads and 36 of the double coated beads were selected and transferred to a 96 well plate. Two drops (approx. 100 microliters) of 0.1 M phosphate buffered saline, pH 6 (PBS) was added to each well and the beads were soaked in the buffer for 40 minutes to permit possible leakage.
A standard curve of diluted HRP was simultaneously set up in separate wells to estimate relative concentrations of enzyme that may have leaked into each of the test wells. A two fold serial dilution of enzyme was prepared in 100 microliters/well of PBS, to give approximately 10, 5, 2.5, 1.25, 0.625, 0.31, WO93/16200 PCT/US93/Ot313 ~,~30~

0.16, 0.08, 0.04, 0.02, 0.01 and 0.005 units/well, that were numbered 1 through 12, respectively.
Then, two drops of the HRP substrate o-phenyldiamine (OPD, 2 mg/ml) and one drop of hydrogen peroxide (0.03%) was added to all wells. Color developed in some wells after approximately 10 minutes, indicating the amount of enzyme present. In the standard curve, wells from 1 to 8 were dark orange. The remaining wells ranged from orange (#9) to very faint yellow (#12), which was considered the borderline between leakage and no detectable leakage. Four control wells without enzyme or beads added, had no color.
The color of each solution in test wells containing beads was then compared to the standard curve wells and assigned a score. A score of less than 12 indicated that detectable enzyme had leaked from the bead.

HRP Drop Bead Test Results Standard Well# <9 9 10 11 12 Units Per Well >0.08 0.04 0.02 0.01 0.005 0 Color dark orange yellow light faint no orange yellow yellow color One Coat Beads 27 3 3 3 o 0 Two Coat Beads 0 0 0 0 2 34 25These results show that waxy polymer coated drop beads can be made that encapsulate enzyme with very little leakage. Also the data show that the double coated beads encapsulated more effectively than the single coated beads, with most of them showing no detectable leakage.
EXANPLE VI
Iniected Beads Made B~ Iniecting Heat-Releasable Reaqent Into Melted Waxy PolYmer In this example, waxy coated liquid droplets, called 35"injected beads", were made by injecting heat-releasable reagent into molten beads of waxy polymer. One microliter volumes of heat-releasable reagent were entrapped in molten wax W O 93/16200 P(~r/US93/01313 213010~

and cooled to form beads that were semi-spherical and had diameters of 3-4 mm. The volume of solution entrappable was restricted by the volume of the molten wax, and by the preci-sion of the injection.
The injection apparatus consisted of two syringes, one for dispensing molten wax beads and the other for injecting the molten wax with heat-releasable reagent. The wax dispensing syringe (5 ml volume) was mounted on a heating rod (18 watt curling iron), and fitted with an 18 gauge stainless steel needle, also in contact with the heating rod. It was filled with molten paraffin wax (m.p. 68C-74C, Fluka Chemical Corp.).
The reagent injecting syringe was a "gastight" 50 microli-ter syringe mounted on a push button, PB600 repeating dispenser (both from Hamilton Co., Reno, Nevada), and fitted with a few centimeters of 30 gauge teflon tubing. The reagent injecting syringe assembly was separate from the heated wax dispensing syringe, but the end of the teflon tubing was held in a small copper wire loop that was mounted on the heating rod. This permitted the wire loop and the teflon tubing tip to be heated near, or above, the wax melting temperature. The wax dispens-ing needle and the teflon tubing were positioned about 0.5-2 cm apart and parallel, with the injection tubing positioned so that injection would be vertical.
The forming surface was a thin plastic film, adhered to the surface of a metal (aluminum, stainless steel) plate.
Strips of polyethylene (Saran~ wrap) were carefully pressed on top of a water droplet to form a seal against the metal. This surface was flat and easily replaced with a clean film after each use.
A variety of heat-releasable reagent compositions were used for injection. For HRP injected beads, HRP enzyme in water or suitable phosphate buffer, and 0.05-0.2% food coloring worked well. For Taq injected beads, Taq DNA polymerase enzyme (5 units/microliter), in the vendor's storage buffer (Boehringer Mannheim Corp., Indianapolis, Indiana), was used.
Generally, the vendor's Taq solution was diluted by 1/3.3 into ,~30~08 a "Taq diluent" consisting of l ml of 75% glycerol in H2O (pH
7.5), 0.15 ml of 0.2 M Tris-EDTA (pH 8), 0.15 ml of l M KCl and 0.2 ml of 0.4-0.5 mg/ml cresol red. This gave a final concen-tration of l.5 units/ml Taq.
To make the injected beads, the steps were:
(l) dispense molten wax (10-50 microliters) to form a liquid wax bead on the plastic film, which cools the bottom of the bead causing it to slowly solidify from the bottom up;
(2) while the bead is still molten, push the heated tip of the injector tubing vertically into the top center of the molten bead; and (3) inject the wax with heat-releasable reagent (l-5 microliters) and remove the tubing.
The injected beads are then allowed to cool to form a completely solid, waxy polymer coating around the injected reagent.
Fig. 2 is a cross sectional diagram showing a molten bead formed on a flat surface (E), after injection of heat-releas-able reagent (B), and before the injector tube (A) has been removed. The outer waxy polymer (D), then cools and solidi-fies.
Fig. 3 is a cross sectional diagram showing a molten bead formed on a flat surface (E), by dispensing molten waxy polymer (D) from a heated dispenser tube (C). The diagram also shows an injector tube (A) leading through, and concentric with, the heated dispenser tube. This is one useful arrangement for keeping the injector tip warm enough to prevent sticking to the waxy polymer. Injection of heat-releasable reagent (B), has just been completed, before the tubing assembly is removed.
The outer waxy polymer (D), then cools and solidifies.
An important parameter in making injected beads is centering the injected droplet in the molten wax bead.
Centering results in maximum wax thickness between the en-trapped droplet and the outside. This is accomplished by inserting the injector tip vertically into the top center of the bead and waiting (O.l-l second) for the bottom of the wax bead to cool and slightly solidify before injection which - 213~ 1~8 prevents the injected reagent from sinking through the bottom.
The metal plate under the plastic surface was useful in reducing static electricity problems and for cooling the bottom of the beads. -Testing Injected Beads Injected beads were tested for encapsulation of HRP using a similar method to that used for the HRP drop beads. The injected beads were made injecting 1 microliter of solution (approx. 0.137 units HRP per microliter in 50% glycerol and 0.1% food coloring, Schilling) by the same procedure as described above. The beads were washed and 54 were placed in a 96 well plate and soaked in 3 drops of PBS for approximately 1 hour. A standard curve of two-fold diluted HRP was prepared in separate wells to contain 0.0685, 0.034, 0.017, 0.0086, 0.0043, 0.0021, 0.0011 and 0.00054 units/well, and numbered 1 through 8.
After soaking, 2 drops of OPD substrate (2 mgtml) were added followed by 1 drop hydrogen peroxide (0.03%). The standard curve wells developed a color gradient down to approximately 0.0043 units per well, but no color was evident in any of the test wells with injected beads. Control wells prepared without enzyme or beads added, also had no color.

HRP Injected Bead Test Results Standard <3 3 4 5 6 7 8 Well#
Units Per >0.017 0.017 0.0086 0.0043 0.0021 0.0011 0.00054 Well dark yellow light faint no no no Color yellow yellow yellow color color color Bead 0 0 0 0 54 Distribution These results show that waxy polymer coated injected beads can be made that encapsulate enzyme with no detectable leakage.
Some of the HRP injected beads were subsequently used to show that heating the beads to melting temperature (above 72C), releases active enzyme.

W093/t6200 ~3~0~ PCT/US93/Ot313 Six of the injected beads were placed in small glass tubes containing a few drops of distilled water and heated over a hot plate until melted. Then a few drops of OPD substrate and hydrogen peroxide were added. Fifty percent of the vials showed orange color indicating enzyme activity.
These results indicate that the HPR injected beads can be used to entrap enzyme and that the enzyme remains active as a heat-releasable reagent.
A PCR test was run to determine the viability of DNA
polymerase (Taq) enzyme in injected beads. Taq injected beads were prepared as previously described.
The PCR procedure was similar to that described previous-ly. The temperature cycling was done in 3 separate water baths at 95C, 72C, and 54C. Capped centrifuge tubes (0.25 ml) were used as reaction vessels and were placed in a plastic pipette rack so that they could be transferred to and from each bath conveniently. Each tube received a total volume of 25 microliters consisting of 10.5 microliters sterile water, 12.5 microliters of 2X buffer to give final approximate concentra-tions of 2.5 m_ MgCl2, 0.15 mM dNTP's, 2% Ficoll, 0.002% xylene cyanole FF and 0.05% BSA. Also added was 2 microliters each of pBR322 DNA template (2 ng), and 10~ M pBR322 primers BamH I, and Pst I (all from Sigma Chem. Co.).
After these solutions were dispensed, each control sample had Taq enzyme added in solution and a drop of mineral oil was added to reduce evaporation. Each test sample had Taq added only as heat-releasable reagent within a Taq injected bead.
Each Taq injected bead contained 1 microliter of solution (1.5 units of Taq in storage buffer with glycerol and cresol red, described previously).
The samples were cycled 35 times, with 2 minutes each of:
denaturation at 95C, annealing at 54C, and extension at 72C.
After cycling, 5 microliters of all 9 control samples but only 5 of the bead each sample was transferred to a 2% agarose gel and electrophoresed in Tris borate EDTA buffer (TBE, pH 8.5), containing ethidium bromide, at approximately 50 volts, 500 milliamps for 45 minutes. The gel showing bands of separated WO93/16200 ~1 3 01 0 8 PCT/US93/01313 products was observed by subillumination using a U.V. lampj and photographed through an orange filter.
The results from a selected group of samples were that eight (89%) out of nine controls tested showed amplified product. All five (lO0~) of the five Taq injected bead samples tested showed amplified product. The results of experiments with HRP or Taq injected beads show that different enzymes are readily encapsulated within, and heat-released from the injected beads of this invention.
EXAMPLE VII
Iniected Beads Made By Iniectinq Into Melted WaxY Polymer Held In A Mold In this example, the previous method for making injected beads was improved by making injected beads in small plastic cups or molds. The molds were rounded depressions (l.5-3 mm diameter and 1-2 mm deep) in thin plastic sheets made by overlaying a perforated plastic or metal plate with a thin plastic sheet (polyethylene or polypropylene) and using heat and vacuum to pull the plastic into the perforations, then cooled.
For the new method using a mold, the steps were:
(l) dispense molten wax (10-50 microliters) to form a liquid wax bead that rests on the bottom of the mold, and touches at least part of the sides of the mold surface;
(2) while the bead is still molten, push the heated tip of the injector tubing vertically into the top center of the molten bead; and (3) inject the wax with heat-releasable reagent (1-5 microliters) and remove the tubing.
The injected beads are allowed to cool to form a solid, waxy polymer coating around the injected reagent.
Fig. 4 is a cross sectional diagram showing a molten bead formed in a cup or mold (F), by dispensing molten waxy polymer (D) from a heated dispenser tube (C). The diagram also shows an injector tube (A) in parallel and in contact with, the heated dispenser tube. This is a useful arrangement for ~3~o~
keeping the injector tip warm enough to prevent sticking to the waxy polymer. Injection of heat-releasable reagent ~B), has just been completed, before the tubing assembly is removed.
The outer waxy polymer (D), then cools and solidifies to form a rounded bottom.
Results Injected beads formed in a mold had more consistent centering of injected reagent, which reduced potential leakage through the wax. The mold worked better apparently because the curvature of the mold tended to cool and slightly solidify the sides of the molten bead as well as the bottom, keeping the injected reagent in the center.
It was also found that suitable injected beads can be made in a strip of molds similar to that shown in Fig. 6. In this example the molds used were strips of hollow, plug-strip caps (Life Science Products Inc., cat# LS 5610). The hollow part of the cap was used as the mold. These polyethylene caps are normally used on micro-titer tubes and are spaced at 9 mm centers.
It was also found that a suitable sleeve to cover the strip caps can be made by laying a strip of clear plastic (acetate) over a strip of strong paper and heat sealing a~ong the edges to form flat tubing with one side plastic and the other paper. Suitable material for this was cut from a "Durapeel" autoclavable pouch (Baxter Healthcare Corp., California). The flat tubing was then slipped over the cap (mold) strips containing the beads and heat sealed at the ends.
A variety of other tubing (i.e., extruded), of the proper size would be suitable.
To dispense the beads into a row of tubes or wells ~i.e., 96 well format), one end of the sleeve is cut off. Then, the entire strip of molds, with beads, is inverted over the tubes and the sleeve is pulled away to let the beads drop into the tubes. It was also found that the strip mold and sleeve assembly can be used simply as a container for other beads such as drop beads.

WO93/16200 2 ~ 3 ~ l 0 8 PCT/US93/01313 -For example, a useful dispenser has been constructed by using "MicroAmp" cap strips (Perkin Elmer Cat. #N801-0534), as the container for the beads which is then slipped inside a length of 5/16 inch I.D., clear plastic tubing (Diamond Straw 5 Inc., Los Angeles, California, Cat. #512C). The advantage is that the container serves a dual purpose as container for the - beads and closure for the reaction vessel. After the beads have been dispensed into the "MicroAmp" reaction tubes, the same cap strip is used to close the reaction tubes. Depending on the type of reaction tube, well or plate used, the corre-sponding caps could be used as the bead containers.
Multiple Dispensing And Injection The injection methods disclosed for making the waxy polymer coated heat-releasable reagents of the instant inven-tion are readily adapted to complete or semi-automated proce-dures. Fig. 5 is a diagram of a device for multiple dispensing of molten waxy polymer beads and injecting them with heat-releasable reagent. The molten waxy polymer is contained in syringes (G), that are kept heated at or above the waxy polymer's melting temperature by heating element (H), which also would be configured to keep the dispenser tubes heated.
When the dispenser plungers (I), are pushed down, melted waxy polymer beads are extruded from the dispenser tubes (C). Then, heat-releasable reagent is injected through injector tubes (A), from injector syringes (J), by pushing on injector plungers (K). Suitably, the plungers I and K are connected to and controlled by precise driving mechanisms such as precision screws that are turned by electronically controlled step motors to dispense microliter volumes consistently. Any suitable number of syringes can be included in this system, preferably with the dispenser and injector tips spaced to fit commercially used formats. Most preferred are sets of 4, 6, 8 or 12 tip assemblies spaced at 9 mm centers to correspond with standard microwell or microtiter formats. Also preferred would be spacing at 4.5 mm to correspond with the new electrophoresis gel combs disclosed herein. In any case, the multiple dispens-ing and injecting can be done on a variety of stationary or ~3 o PCr/US93/01313 movable surfaces, and include the use of cups or molds as previously described.

EXaMPLE VI I I
5DiPped-Liquid Beads Suitable beads can also be made by dipping liquid droplets into molten waxy polymer to coat them. In this example, an aqueous solution of 2:1 sucrose to water, containing approxi-mately 0.1% food coloring was used. A hanging droplet of 2-4 10microliters was formed on the end of small (2-3 mm O.D.) plastic tubing (i.e., on a syringe), and cooled in a freezer until suitably viscous (or sometimes frozen in a dry ice chamber). Then, the droplet and tubing was dipped into molten paraffin wax approximately 1-3 mm above the droplet, and 15quickly removed to let solidify. This was repeated 2-4 times to form an encapsulated droplet. When the entrapped droplet is pulled off of the tubing, it has a narrow wax "neck" from where the tubing was. With the droplet held upright, the neck is gently heated with a hot wire to re-melt only the wax neck and 20thereby seal the top. These colored liquid filled beads were tested for leakage by soaking them in water several days and no loss of coloring was seen. This method could be automated and used for entrapment of the heat-releasable reagents of this invention.
EX~MPLE IX
Wax Tubes Containing Heat-Releasable Reaqent This example shows that any suitable aqueous liquid can be entrapped in fine wax tubes and the tubes can be cut to a 30certain length and simultaneously sealed to make small dispens-able packages. In this example, a small wax tube was made by dipping a cold needle into molten wax in a hot water bath.
Several coatings could be achieved by cooling the wax tube before each dip. After 2-3 coatings and while the wax was 35still warm, the wax tube was removed by pushing it off the needle while still warm. The tube was then injected with colored water and the ends were sealed by heating with a hot W093/16200 2 1 ~ 0~ ~ 8 PCT/US93/01313 wire. No leakage occurred after immersion of the container in cold water.
While the invention has been described with references to certain specific embodiments, it is understood that changes may be made by one skilled in the art and it would not thereby depart from the spirit and scope of the invention which is limited only by the claims appended hereto.
What is claimed is:

Claims (31)

1. A method for producing a heat-releasable in vitro reagent comprising the steps of:
(a) entrapping a heat resistant enzyme selected from the group consisting of DNA polymerases, RNA polymerases, ligases, reverse transcriptases, restriction endonucleases, kinases, proteases, nucleases, DNAses, RNAses, phosphatases, and peroxidases, within a heat-releasable material which is substantially water insoluble and which has a melting temperature greater than 30°C; and (b) forming said heat-releasable material with entrapped enzyme into a mobile dispensable body.
2. The method of claim 1, wherein the heat-releasable material is a waxy polymer.
3. The method of claim 1, wherein the heat-releasable material is a heat-releasable gel.
4. The method of claim 1, wherein the heat-releasable material is a liposome.
5. A method for producing a heat-releasable in vitro reagent comprising the steps of:
(a) entrapping a heat resistant reagent within a heat-releasable material which is substantially water insoluble and which has a melting temperature greater than 30°C, said heat resistant reagent being selected from the group consisting of labeled and unlabeled nucleotides, deoxynucleoside triphosphates, dideoxynucleoside triphosphates, ribonucleoside triphosphates, oligonucleotides, DNA, RNA, and analogs thereof; and (b) forming said heat-releasable material with entrapped reagent into a mobile dispensable body.
6. The method of claim 5, wherein the heat-releasable material is a waxy polymer.
7. The method of claim 5, wherein the heat-releasable material is a heat-releasable gel.
8. The method of claim 5, wherein the heat-releasable material is a liposome.
9. A method for producing a heat-releasable in vitro reagent comprising the steps of:
(a) entrapping a heat resistant reagent within a heat-releasable material which is substantially water insoluble and which has a melting temperature greater than 30°C, said heat resistant reagent being selected from the group consisting of antibodies, antigens, labelling substances, avidins, streptavidins, biotins, enzyme inhibitors, and chelating agents; and (b) forming said heat-releasable material with entrapped reagent into a mobile dispensable body.
10. The method of claim 9, wherein the heat-releasable material is a waxy polymr.
11. The method of claim 9, wherein the1651Xheat-releasable material is a heat-relasable gel.
12. The method of claim 9, wherein the heat-releasable material is a liposome.
13. A method for producing a heat-releasable in vitro reagent comprising the steps of:
(a) entrapping a metal salt within a waxy-polymer which is substantially water insoluble and which has a melting temperature greater than 30°C, said metal salt containing a metal selected from the group consisting of Mg, Mn, Fe, Co, Cu and Zn; and (b) forming said waxy-polymer with entrapped metal salt into a mobile dispensable body.
14. A method for producing a heat-releasable in vitro reagent composition comprising the steps of:
(a) injecting a solution containing a heat resistant reagent into a bead of molten waxy polymer having a melting temperature greater than 30°C; and (b) forming said waxy polymer with entrapped reagent into a mobile dispensable body, such that said mobile dispensable body is substantially water insoluble.
15. The method of claim 14, wherein the reagent is an enzyme selected from the group consisting of DNA polymerases, RNA polymerases, ligases, reverse transcriptases, restriction endonucleases, kinases, proteases, nucleases, DNAses, RNAses, phosphatases and peroxidases.
16. The method of claim 14, wherein the reagent is selected from the group consisting of labeled and unlabeled nucleotides, deoxynucleoside triphosphates, dideoxynucleoside triphosphates, ribonucleoside triphosphates, oligonucleotides, DNA, RNA and analogs thereof.
17. The method of claim 14, wherein the reagent is a metal salt containing a metal selected from the group consisting of Mg, Mn, Fe, Co, Cu and Zn.
18. The method of claim 14, wherein the reagent is selected from the group consisting of labelling substances, avidins, streptavidins, and biotins.
19. The method of claim 14, wherein the reagent is selected from the group consisting of antibodies and antigens.
20. The method of claim 14, wherein the dispensable body is formed in a mold.
21. A method for producing a heat-releasable in vitro reagent composition comprising the steps of:
(a) dropping a solution containing a heat resistant reagent through a molten layer of waxy polymer having a melting temperature greater than 30°C; and (b) forming a bead of waxy polymer with said reagent entrapped within said bead, such that said bead is substantially water insoluble.
22. The method of claim 21, wherein the reagent is an enzyme selected from the group consisting of DNA polymerases, RNA polymerases, ligases, reverse transcriptases, restriction endonucleases, kinases, proteases, nucleases, DNAses, RNAses, phosphatases and peroxidases.
23. The method of claim 21, wherein the reagent is selected from the group consisting of labeled and unlabeled nucleotides, deoxynucleoside triphosphates, dideoxynucleoside triphosphates, ribonucleoside triphosphates, oligonucleotides, DNA, RNA and analogs thereof.
24. The method of claim 21, wherein the reagent is selected from the group consisting of antibodies and antigens.
25. The method of claim 21, wherein the reagent is selected from the group consisting of labelling substances, avidins, streptavidins, and biotins.
26. The method of claim 21, wherein the reagent is selected from the group consisting of enzyme inhibitors and chelating agents.
27. A method for initiating an in vitro reaction with a heat-releasable reagent comprising the steps of:
(a) adding a meltable dispensable body containing a heat-releasable reagent to a medium capable of reaction with said reagent, said dispensable body being made from a meltable, substantially water insoluble material having a melting temperature greater than 30°C and said heat-releasable reagent being selected from the group consisting of DNA polymerases, RNA polymerases, ligases, reverse transcriptases, restriction endonucleases, kinases, proteases, nucleases, DNAses, RNAses, phosphatases, peroxidases, labeled and unlabeled nucleotides, deoxynucleoside triphosphates, dideoxynucleoside triphosphates, ribonucleoside triphosphates, oligonucleotides, DNA, RNA, antibodies, antigens, and metal salts containing a metal selected from Mg, Mn, Fe, Co, Cu, and Zn; and (b) heating said medium and said dispensable body up to or above the melting point of said dispensable body, such that said reagent is released into said medium.
28. The method of claim 27, wherein the dispensable body includes the reagent evenly dispersed within the meltable, substantially water insoluble material.
29. The method of claim 27, wherein the dispensable body includes the reagent entrapped within the meltable, substan-tially water insoluble material.
30. A mobile, dispensable body containing an entrapped heat resistant enzyme selected from the group consisting of DNA
polymerases, RNA polymerases, ligases, reverse transcriptases, restriction endonucleases, kinases, proteases, nucleases, DNAses, RNAses, phosphatases, and peroxidases, within a waxy polymer which is substantially water insoluble and which has a melting temperature greater than 30°C.
31. A mobile, dispensable body containing an entrapped heat resistant reagent within a waxy polymer which is substantially water insoluble and which has a melting temperature greater than 30°C, said heat resistant reagent being selected from the group consisting of labeled and unlabeled nucleotides, deoxynucleoside triphosphates, dideoxynucleoside triphosphates, ribonucleoside triphosphates, oligonucleotides, DNA, RNA, and analogs thereof.
CA002130108A 1992-02-13 1993-02-12 Heat-releasable reagents for in vitro chemical reactions Expired - Fee Related CA2130108C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US835,758 1992-02-13
US83575892A 1992-02-14 1992-02-14
US07/936,357 US5413924A (en) 1992-02-13 1992-08-27 Preparation of wax beads containing a reagent for release by heating
US936,357 1992-08-27

Publications (2)

Publication Number Publication Date
CA2130108A1 CA2130108A1 (en) 1993-08-19
CA2130108C true CA2130108C (en) 1996-02-06

Family

ID=27125815

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002130108A Expired - Fee Related CA2130108C (en) 1992-02-13 1993-02-12 Heat-releasable reagents for in vitro chemical reactions

Country Status (5)

Country Link
US (3) US5413924A (en)
EP (1) EP0626017A1 (en)
AU (1) AU661768B2 (en)
CA (1) CA2130108C (en)
WO (1) WO1993016200A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110218777A (en) * 2019-06-14 2019-09-10 苏州叠代生物科技有限公司 PCR premixed liquid

Families Citing this family (177)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985327A (en) 1988-10-05 1999-11-16 Flinders Technologies Pty. Ltd. Solid medium and method for DNA storage
US5972386A (en) * 1995-12-19 1999-10-26 Flinders Technologies Pty, Ltd. Dry solid medium for storage and analysis of genetic material
US6447804B1 (en) 1988-10-05 2002-09-10 Whatman, Plc Dry solid medium for storage and analysis of genetic material
US20040014068A1 (en) * 1988-10-05 2004-01-22 Whatman, Inc. Solid medium and method for DNA storage
US5413924A (en) * 1992-02-13 1995-05-09 Kosak; Kenneth M. Preparation of wax beads containing a reagent for release by heating
EP0572057A1 (en) * 1992-05-11 1993-12-01 Johnson &amp; Johnson Clinical Diagnostics, Inc. PCR reagent composition, test kit and methods for amplification and detection with reduced nonspecific amplification of nucleic acids
US5837453A (en) * 1992-05-13 1998-11-17 Geron Corporation Telomerase activity assays
US5629154A (en) * 1993-11-12 1997-05-13 Geron Corporation Telomerase activity assays
US5599660A (en) * 1993-01-19 1997-02-04 Pharmacia Biotech Inc. Method and preparation for sequential delivery of wax-embedded, inactivated biological and chemical reagents
US5965454A (en) * 1993-02-03 1999-10-12 Histaggen Incorporated Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials
DE69430679T2 (en) * 1993-02-03 2002-12-19 Histaggen Inc A method of storing a ligand in a releasable container and a method of releasing a ligand therefrom
US6410277B1 (en) * 1993-02-19 2002-06-25 Takara Shuzo Co., Ltd. DNA polymersases with enhanced length of primer extension
US5556773A (en) * 1993-08-06 1996-09-17 Yourno; Joseph Method and apparatus for nested polymerase chain reaction (PCR) with single closed reaction tubes
WO1995005455A1 (en) * 1993-08-13 1995-02-23 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
US5863726A (en) * 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
US5804380A (en) * 1993-11-12 1998-09-08 Geron Corporation Telomerase activity assays
US5968729A (en) * 1994-06-10 1999-10-19 Kosak; Kenneth M. Use of centrifugation to prepare a retractable seal over reagents in a reaction container
US5879950A (en) * 1994-06-22 1999-03-09 Kinnunen; Paavo Kai Johannes Materials and methods for digestion of DNA or RNA using restriction endonucleases
US5792612A (en) * 1994-06-22 1998-08-11 Helsinki University Licensing, Ltd. Use of lipids to improve the polymerse chain reaction
US5605796A (en) * 1994-07-19 1997-02-25 Behringwerke Ag Method for preventing amplification of nucleic acid contaminants in amplification mixtures using nuclease-receptor conjugates
US5576197A (en) * 1995-04-07 1996-11-19 Molecular Bio-Products Polymerase chain reaction container and methods of using the same
GB9509336D0 (en) * 1995-05-09 1995-06-28 Dynal As Chemical method
WO1996040900A1 (en) * 1995-06-07 1996-12-19 Helsinki University Licensing Ltd. Oy Materials and methods for the polymerase chain reaction
JPH10509330A (en) * 1995-09-12 1998-09-14 ベクトン・ディッキンソン・アンド・カンパニー Apparatus and methods for DNA amplification and assays
US5851805A (en) * 1997-01-16 1998-12-22 Board Of Trustees Operating Michigan State University Method for producing DNA from mRNA
US6664044B1 (en) * 1997-06-19 2003-12-16 Toyota Jidosha Kabushiki Kaisha Method for conducting PCR protected from evaporation
ES2283936T3 (en) 1997-07-07 2007-11-01 Medical Research Council IN VITRO CLASSIFICATION PROCEDURE.
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
GB9900298D0 (en) * 1999-01-07 1999-02-24 Medical Res Council Optical sorting method
EP1173557A1 (en) * 1999-04-23 2002-01-23 Nexttec GmbH Method for encapsulating macromolecules and/or particles and use thereof
US6565342B1 (en) * 2000-11-17 2003-05-20 Accurus Scientific Co. Ltd. Apparatus for making precision metal spheres
US6428962B1 (en) 2001-02-12 2002-08-06 Dna Analysis, Inc. Nucleic acid collection barrier method and apparatus
US6518330B2 (en) * 2001-02-13 2003-02-11 Board Of Trustees Of University Of Illinois Multifunctional autonomically healing composite material
US7833701B2 (en) * 2001-05-11 2010-11-16 Panasonic Corporation Biomolecule substrate, and test and diagnosis methods and apparatuses using the same
NZ511680A (en) * 2001-05-14 2004-07-30 Univ Waikato Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
GB0127564D0 (en) 2001-11-16 2002-01-09 Medical Res Council Emulsion compositions
EP1488006B1 (en) * 2002-03-20 2008-05-28 InnovativeBio.Biz Microcapsules with controlable permeability encapsulating a nucleic acid amplification reaction mixture and their use as reaction compartments for parallels reactions
US20030186252A1 (en) * 2002-04-01 2003-10-02 Ilsley Diane D. Array based hybridization assays employing enzymatically generated labeled target nucleic acids and compositions for practicing the same
GB2399084B (en) * 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
CL2004000922A1 (en) 2003-05-01 2005-05-06 Veridex Llc METHOD AND DIAGNOSTIC EQUIPMENT TO PERFORM A DIAGNOSTIC TEST OF LYMPHATIC GANGLY, DURING THE DEVELOPMENT OF A SURGICAL PROCEDURE AND DETECTING MORE THAN A GENICAL MARKER THAT EXCEED AN EXCLUSION VALUE.
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
ES2401148T3 (en) * 2004-04-16 2013-04-17 Bredent Medical Gmbh & Co. Kg Preparation to photodynamically combat microorganisms and use of the preparation
EP1737492B9 (en) * 2004-04-16 2013-04-10 bredent medical GmbH & Co. KG Preparation for the photodynamic control of micro-organisms and use of said preparation
RU2259401C1 (en) * 2004-04-27 2005-08-27 Общество с ограниченной ответственностью "Компания "Биоком" (ООО "Компания "Биоком") Dry mixture of reagents for polymerase chain reaction and method for carrying out pcr-analysis
DE102004021780B4 (en) * 2004-04-30 2008-10-02 Siemens Ag Method and device for DNA isolation with dry reagents
DE102004021822B3 (en) * 2004-04-30 2005-11-17 Siemens Ag Method and arrangement for DNA amplification by means of PCR using dry reagents
US7566747B2 (en) * 2004-05-07 2009-07-28 The Board Of Trustees Of The University Of Illinois Wax particles for protection of activators, and multifunctional autonomically healing composite materials
AU2005250479B2 (en) * 2004-06-04 2010-07-22 Veridex, Llc Diagnosing or predicting the course of breast cancer
CN101426908B (en) * 2004-06-09 2014-06-11 纽星实验室 Reversibly modified thermostable enzyme compositions and methods of making and using the same
AU2005253903B2 (en) * 2004-06-17 2010-07-01 Zygem Corporation Limited Purification methods and uses thereof
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP1674085A1 (en) * 2004-12-22 2006-06-28 Universite Libre De Bruxelles Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation
US7304300B2 (en) * 2005-03-15 2007-12-04 Battelle Energy Alliance, Llc Infrared tag and track technique
US20060228734A1 (en) * 2005-03-18 2006-10-12 Applera Corporation Fluid processing device with captured reagent beads
JP4237184B2 (en) * 2005-03-31 2009-03-11 エルピーダメモリ株式会社 Manufacturing method of semiconductor device
US20060263811A1 (en) * 2005-05-03 2006-11-23 Geunsook Jeon Materials and kits for use in hot-start PCR, and methods of amplifying nucleic acids in a polymerase chain reaction
US7612152B2 (en) * 2005-05-06 2009-11-03 The Board Of Trustees Of The University Of Illinois Self-healing polymers
EP1748084A1 (en) * 2005-07-28 2007-01-31 Roche Diagnostics GmbH Analytical method and device
US20070026442A1 (en) * 2005-07-28 2007-02-01 Roche Molecular Systems, Inc. Analytical method and device
EP1748081A1 (en) * 2005-07-28 2007-01-31 Roche Diagnostics GmbH Analytical method and device
US8530194B2 (en) * 2005-09-26 2013-09-10 Allelogic Biosciences Corporation Oligonucleotides as temperature-sensitive inhibitors for DNA polymerases
US7723405B2 (en) 2006-01-05 2010-05-25 The Board Of Trustees Of The University Of Illinois Self-healing coating system
EP3913375A1 (en) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
ITTO20060063A1 (en) * 2006-01-31 2007-08-01 Clonit S R L KIT FOR THE AMPLIFICATION OF NUCLEIC ACIDS.
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US20080014589A1 (en) 2006-05-11 2008-01-17 Link Darren R Microfluidic devices and methods of use thereof
US7569625B2 (en) * 2006-06-02 2009-08-04 The Board Of Trustees Of The University Of Illinois Self-healing elastomer system
NZ548731A (en) * 2006-07-24 2008-12-24 Zygem Corp Ltd Isothermal detection methods and uses thereof
US9045522B2 (en) 2006-07-31 2015-06-02 Wanli Bi Nucleic acid amplification using a reversibly modified oligonucleotide
JP2009545316A (en) * 2006-07-31 2009-12-24 ワンリ ビ Nucleic acid amplification using reversibly modified oligonucleotides
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
DE102006045821A1 (en) * 2006-09-28 2008-04-03 Wötzer, Philipp Display device and frozen food packaging
GB0619442D0 (en) * 2006-10-02 2006-11-08 Q Chip Ltd Beads for use in reactions for the amplification and/or synthesis of a polynucleotide
EP1932922A1 (en) * 2006-12-13 2008-06-18 Desitin Arzneimittel GmbH In situ hybridisation detection of DNA squences
US20080286408A1 (en) * 2006-12-28 2008-11-20 Philip Morris Usa Inc. Encapsulation of a hydrophilic substance in small capsules
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20080299391A1 (en) * 2007-05-31 2008-12-04 White Scott R Capsules, methods for making capsules, and self-healing composites including the same
GB0711683D0 (en) * 2007-06-16 2007-07-25 Enigma Diagnostics Ltd Compositions
WO2009063381A1 (en) * 2007-11-12 2009-05-22 Firmenich Sa Mouthfeel enhancing ingredients
WO2009133473A2 (en) * 2008-01-08 2009-11-05 Zygem Corporation Limited Isothermal detection methods and uses thereof
US20090181254A1 (en) * 2008-01-15 2009-07-16 The Board Of Trustees Of The University Of Illinois Multi-capsule system and its use for encapsulating active agents
WO2009137807A2 (en) 2008-05-08 2009-11-12 Asuragen, Inc. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
CA2689472C (en) * 2008-07-18 2019-01-15 Karine Theberge Articles of manufacture releasing an active ingredient
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
EP2324128A4 (en) * 2008-08-14 2012-09-12 Zygem Corp Ltd Temperature controlled nucleic-acid detection method suitable for practice in a closed-system
IT1397110B1 (en) * 2008-12-29 2012-12-28 St Microelectronics Rousset SELF-SEALING MICROREACTOR AND METHOD TO CARRY OUT A REACTION
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2010117456A2 (en) * 2009-04-08 2010-10-14 Applied Biosystems, Llc Column enrichment of pcr beads comprising tethered amplicons
AU2010249421A1 (en) 2009-05-22 2011-12-08 Asuragen, Inc. miRNA biomarkers of prostate disease
IL206810A (en) 2009-07-08 2015-07-30 Janssen Diagnostics Llc Methods of identifying melanoma and kits for use therein
EP2775300A3 (en) 2009-08-28 2015-04-01 Asuragen, INC. miRNA Biomarkers of Lung Disease
EP2480256A4 (en) * 2009-09-23 2014-06-25 Univ California Chemically amplified response strategies for medical sciences
EP2486409A1 (en) 2009-10-09 2012-08-15 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP3392349A1 (en) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Digital analyte analysis
US9410194B2 (en) 2010-06-21 2016-08-09 Life Technologies Corporation Compositions, kits and methods for synthesis and/or detection of nucleic acids
EP2586861B1 (en) 2010-06-22 2017-10-25 Universal Bio Research Co., Ltd. Composition for preventing evaporation of reaction solution during nucleic acid amplification reaction
EP2418286A1 (en) * 2010-08-10 2012-02-15 QIAGEN GmbH Improved method for isothermal amplification of nucleic acids
WO2012024103A2 (en) * 2010-08-17 2012-02-23 Rheonix, Inc. Thermocycler seal composition, method, and application
EP3447155A1 (en) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwich assays in droplets
CA2817882C (en) 2010-11-17 2022-08-23 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
US9801831B2 (en) * 2010-12-30 2017-10-31 Nanyang Technological University Device for controlled release of a bioactive agent
WO2012109600A2 (en) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
EP3709018A1 (en) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Microfluidic apparatus for identifying components of a chemical reaction
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
TWI525184B (en) 2011-12-16 2016-03-11 拜歐菲樂Ip有限責任公司 Cryogenic injection compositions, systems and methods for cryogenically modulating flow in a conduit
GB2500658A (en) * 2012-03-28 2013-10-02 Dna Electronics Ltd Biosensor device and system
US10273541B2 (en) 2012-08-14 2019-04-30 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
MX364957B (en) 2012-08-14 2019-05-15 10X Genomics Inc Microcapsule compositions and methods.
US10400280B2 (en) 2012-08-14 2019-09-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP3567116A1 (en) 2012-12-14 2019-11-13 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2014124338A1 (en) 2013-02-08 2014-08-14 10X Technologies, Inc. Polynucleotide barcode generation
US9868992B2 (en) 2013-03-15 2018-01-16 Baylor Research Institute Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
US9758835B2 (en) 2013-03-15 2017-09-12 Baylor Research Institute Ulcerative colitis (UC)-associated colorectal neoplasia markers
US10395758B2 (en) 2013-08-30 2019-08-27 10X Genomics, Inc. Sequencing methods
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9474720B2 (en) 2013-11-04 2016-10-25 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US10160966B2 (en) 2013-12-12 2018-12-25 Altratech Limited Sample preparation method and apparatus
US10746683B2 (en) * 2013-12-12 2020-08-18 Altratech Limited Capacitive sensor and method of use
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
EP3090063B1 (en) 2013-12-31 2019-11-06 Bio-Rad Laboratories, Inc. Method for detection of latent retrovirus
BR112016015595A2 (en) 2014-01-05 2017-10-24 Biomirna Holdings Ltd lung cancer determination methods
US10619210B2 (en) 2014-02-07 2020-04-14 The Johns Hopkins University Predicting response to epigenetic drug therapy
EP3129143B1 (en) 2014-04-10 2022-11-23 10X Genomics, Inc. Method for partitioning microcapsules
JP6403809B2 (en) * 2014-06-18 2018-10-10 ルミネックス コーポレーション Method for making stabilized lyophilized material
CN106795553B (en) 2014-06-26 2021-06-04 10X基因组学有限公司 Methods of analyzing nucleic acids from individual cells or cell populations
CN110211637B (en) 2014-06-26 2023-10-27 10X基因组学有限公司 Method and system for assembling nucleic acid sequences
EP3212807B1 (en) 2014-10-29 2020-09-02 10X Genomics, Inc. Methods and compositions for targeted nucleic acid sequencing
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
WO2016094330A2 (en) 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
US10221436B2 (en) 2015-01-12 2019-03-05 10X Genomics, Inc. Processes and systems for preparation of nucleic acid sequencing libraries and libraries prepared using same
WO2016115273A1 (en) 2015-01-13 2016-07-21 10X Genomics, Inc. Systems and methods for visualizing structural variation and phasing information
US10854315B2 (en) 2015-02-09 2020-12-01 10X Genomics, Inc. Systems and methods for determining structural variation and phasing using variant call data
EP3262188B1 (en) 2015-02-24 2021-05-05 10X Genomics, Inc. Methods for targeted nucleic acid sequence coverage
WO2016137973A1 (en) 2015-02-24 2016-09-01 10X Genomics Inc Partition processing methods and systems
EP3292214A1 (en) 2015-05-04 2018-03-14 Academisch Medisch Centrum Method of quantifying mirnas using normalization
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
EP3384048B1 (en) 2015-12-04 2021-03-24 10X Genomics, Inc. Methods and compositions for nucleic acid analysis
US11081208B2 (en) 2016-02-11 2021-08-03 10X Genomics, Inc. Systems, methods, and media for de novo assembly of whole genome sequence data
WO2017177025A1 (en) 2016-04-06 2017-10-12 Life Technologies Corporation Compositions, methods, and kits for synthesis and detection of nucleic acids
WO2017197338A1 (en) 2016-05-13 2017-11-16 10X Genomics, Inc. Microfluidic systems and methods of use
RU171152U1 (en) * 2016-09-07 2017-05-22 Мераб Георгиевич Чикобава DOSED FORM FOR POLYMERASE CHAIN REACTION
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP4029939B1 (en) 2017-01-30 2023-06-28 10X Genomics, Inc. Methods and systems for droplet-based single cell barcoding
WO2018144906A1 (en) * 2017-02-02 2018-08-09 University Of Maryland, College Park Trap arrays for robust microfluidic sample digitization
EP3625715A4 (en) 2017-05-19 2021-03-17 10X Genomics, Inc. Systems and methods for analyzing datasets
US10844372B2 (en) 2017-05-26 2020-11-24 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
SG11201901822QA (en) 2017-05-26 2019-03-28 10X Genomics Inc Single cell analysis of transposase accessible chromatin
CN107083623B (en) * 2017-06-14 2023-01-10 朱月眉 Bead stringing device and bead embroidering machine with same
EP4219751A1 (en) 2017-09-20 2023-08-02 Altratech Limited Diagnostic device and system
EP3954782A1 (en) 2017-11-15 2022-02-16 10X Genomics, Inc. Functionalized gel beads
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
WO2019195166A1 (en) 2018-04-06 2019-10-10 10X Genomics, Inc. Systems and methods for quality control in single cell processing
EP3719144A1 (en) 2019-04-05 2020-10-07 Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) Mir-151a-3p as an universal endogenous control for exosome cargo normalization
EP3999664A1 (en) 2019-07-19 2022-05-25 Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) Method for determining the response to treatment of a patient affected by non-small cell lung carcinoma (nsclc)
DE202020004407U1 (en) * 2020-10-20 2020-11-24 Friz Biochem Gmbh Functionalized microtiter plate, reaction solution, and kit for preparing a reaction solution
WO2023209606A1 (en) * 2022-04-29 2023-11-02 Illumina Cambridge Limited Methods and systems for encapsulating lyophilised microspheres

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868199A (en) * 1971-06-04 1975-02-25 Jose Fera Apparatus for producing powered paraffin
DE2713463C2 (en) * 1977-03-26 1982-02-04 Kernforschungsanlage Jülich GmbH, 5170 Jülich Nuclear power plant with gas-cooled reactor core
US4303717A (en) * 1979-08-23 1981-12-01 Commercial Decal, Inc. Heat release layer for decalcomanias
US4384835A (en) * 1981-07-27 1983-05-24 Bland Roger P Apparatus for the production of beads from molten materials
US4607050A (en) * 1981-10-19 1986-08-19 Wellcome Australia Limited Method of controlling insects and parasites with an aqueous localized pour-on formulation
US4749620A (en) * 1984-02-15 1988-06-07 Massachusetts Institute Of Technology Encapsulated active material system
US4743548A (en) * 1984-09-25 1988-05-10 Calgene, Inc. Plant cell microinjection technique
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
PH24970A (en) * 1987-08-25 1990-12-26 Gist Brocades Nv Food-grade oxygen scavenger for water containing products
FR2627404A1 (en) * 1988-02-24 1989-08-25 Total France Coating particles with low m.pt material - by passing them through molten material under inert atmos. and collecting them when coating has solidified
DE3808531C1 (en) * 1988-03-15 1989-07-13 Eppendorf - Netheler - Hinz Gmbh, 2000 Hamburg, De
US5000955A (en) * 1988-07-29 1991-03-19 Tyndale Plains-Hunter Ltd. Thermally reversible polyurethane hydrogels and cosmetic, biological and medical uses
US5093130A (en) * 1989-09-26 1992-03-03 Plant Genetics Powder coated hydrogel capsules
US5200236A (en) * 1989-11-15 1993-04-06 Lever Brothers Company, Division Of Conopco, Inc. Method for wax encapsulating particles
WO1991012342A1 (en) * 1990-02-16 1991-08-22 F. Hoffmann-La Roche Ag Improvements in the specificity and convenience of the polymerase chain reaction
SE465086B (en) * 1990-05-16 1991-07-22 Mats Malmquist RESPONSIBILITIES, REACTIONS, PREPARATION METHOD AND APPLICATION THEREOF
US5130343A (en) * 1991-03-13 1992-07-14 Cornell Research Foundation, Inc. Process for producing uniform macroporous polymer beads
US5413924A (en) * 1992-02-13 1995-05-09 Kosak; Kenneth M. Preparation of wax beads containing a reagent for release by heating

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110218777A (en) * 2019-06-14 2019-09-10 苏州叠代生物科技有限公司 PCR premixed liquid

Also Published As

Publication number Publication date
WO1993016200A1 (en) 1993-08-19
AU661768B2 (en) 1995-08-03
US5550044A (en) 1996-08-27
EP0626017A1 (en) 1994-11-30
CA2130108A1 (en) 1993-08-19
US5643764A (en) 1997-07-01
AU3619193A (en) 1993-09-03
US5413924A (en) 1995-05-09

Similar Documents

Publication Publication Date Title
CA2130108C (en) Heat-releasable reagents for in vitro chemical reactions
AU2021202347B2 (en) Cell separation devices, systems, and methods
US6251661B1 (en) Seamless capsule for synthesizing biopolymer and method for producing the same
US4798786A (en) Living cells encapsulated in crosslinked protein
CA2206602C (en) Sequential delivery of purified biological and chemical reagents
JP3087907B2 (en) Improvement of specificity and simplicity of polymerase chain reaction
JP6955540B2 (en) Methods for making stabilized lyophilized material
JPS58500063A (en) Pellet, microbead, microcapsule and their manufacturing method
US4353888A (en) Encapsulation of live animal cells
US5104736A (en) Reinforced paucilamellar lipid vesicles
JP2010503410A (en) Preparation of vitrified biological reagents
EP3714269B1 (en) A microcapsule for detecting and/or quantitating an analyte in a sample
NZ265818A (en) Compositions of nucleic acids encapsulated with molecules that facilitate uptake and integration into living cells
US4284719A (en) Substrate composition and use thereof
JPH0622796A (en) Polymerase chain reaction reagent composition for reducing non-specific amplification of nucleic acid, test kit and amplifying and detecting method
AU625857B2 (en) Gelcores
EP0129619B1 (en) Encapsulated cells, their method of preparation and use
US5968729A (en) Use of centrifugation to prepare a retractable seal over reagents in a reaction container
Carter et al. Isolation of hamster intestinal epithelial cells using hypoosmotic media and PVP
Nagatomo et al. High permeability of polyunsaturated lipid bilayers as applied to attoliter enzyme reactors
EP3399034B1 (en) Device for extracting nucleic acids from biological sample materials with solvent-free reagents
TARRAGO‐LITVAK et al. DNA Polymerases of Anucleated Cells: Isolation and Characterization of Two DNA Polymerases from Human Platelets
Lal Use of pH-triggered liposomes as a drug controlled delivery device
JPS6025929A (en) Encapsulated cell, manufacture and use
JPS6290537A (en) Method of detecting component of substance to be analyzed bysignal localization

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed